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Abstract 
Objective: To explore the association between family functioning and mental health 
in children with cystic fibrosis. 
Methods: A systematic search was conducted to identify papers reporting on an 
association between a child mental health variable and a measure of family/parental 
functioning. Search terms yielded 26 articles suitable for review. Studies were rated 
for quality and 11 “poor” quality articles excluded from quantitative synthesis. 
Participants included 1740 children and 1684 parent/caregivers (median number of 
families per study = 49.0). 
Results: In all cross-sectional studies, at least one measure of family functioning was 
associated with a child mental health measure. Associations with parenting stress 
were mixed. In longitudinal designs, significant associations diminished by year three 
follow-up.  
Conclusions: Less adaptive family functioning is associated with poorer child mental 
health in all cross-sectional studies except two. Clinically, results suggest the 
importance of the inclusion of family and parental functioning in assessments of 
emotional needs, to ascertain if individual or systemic intervention is warranted. An 
understanding of which family functioning factors are associated with child 
psychological wellbeing may also inform future systemic interventions for children with 
cystic fibrosis and their families.  
 
Key words: systematic review; cystic fibrosis; mental health; children; family 
functioning 
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Introduction 
Cystic fibrosis (CF) is a life-limiting genetic condition, affecting around 10,400 people 
in the UK and 100,000 worldwide (Cystic Fibrosis Trust, n.d). Abnormalities in salt 
transport around the body lead to a build-up of mucous, affecting the lungs 
predominantly but also other organs (Elborn, 2016). CF treatment involves a time-
intensive daily management regime (Ziaian et al., 2006), which can be burdensome 
for both the individual and family. Furthermore, it is recommended that individuals with 
CF are segregated for infection control reasons (Cystic Fibrosis Trust, 2004) and so 
family emotional support may be of increased importance due to a lack of face-to-face 
peer support. Those with CF and their caregivers experience increased rates of 
anxiety and depression, such that routine screening of these difficulties is 
recommended (Quittner et al., 2016). The practical and psychological toll of CF, 
therefore, can be a source of pressure on the family system. As such, it is of 
importance that the emotional needs of those with CF and their families are 
understood and met.  
 
Family Functioning in Paediatric Chronic Health Conditions 
Studies exploring interactions between childhood chronic health conditions and family 
functioning have found mixed results. Herzer et al. (2010) analysed studies which used 
the Family Assessment Device in healthy children and children with CF, obesity, sickle 
cell disease, inflammatory bowel disease and epilepsy. For children with CF (n = 59), 
22% of families were rated in the “unhealthy” range for overall family functioning, 
however, this was not significantly different to the functioning of other groups (range 
23-32%).  To examine the differences in family functioning between families of children 
with health conditions and those without, McClellan and Cohen (2007) reviewed six 
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studies featuring a group with CF. Two reported enhanced functioning, three reported 
poorer functioning and one found no significant differences. All studies had relatively 
small sample sizes (group with CF mean n = 29, range = 15-41), and all but two used 
different measures. In a broad review of studies on CF and the family, Berge and 
Patterson (2004) similarly found mixed results. Again, studies tended to have small 
sample sizes (mean n = 29, range = 23-41). Possibly, small sample sizes and varied 
measures of family functioning have contributed to inconsistencies. Indeed, Alderfer 
et al. (2008) suggest that family functioning in paediatric populations cannot 
necessarily be compared with healthy populations and that ostensibly problematic 
family interactions may be functional in the context of a chronic health condition. The 
authors suggest that, for example, circumscribed roles may promote treatment 
management. Inflexibility of roles and routine may facilitate consistent adherence to 
daily regimes of CF care, whereas in healthy populations role inflexibility may be 
considered problematic.   
 
Family Functioning and Child Mental Health 
Assessing the relationship of family functioning with clinically relevant variables, such 
as the child’s psychological health, could help identify potentially modifiable targets for 
intervention. Drotar (1997) reviewed 50 studies examining family functioning in a wide 
range of chronic paediatric health conditions including CF, with 46 reporting on 
significant associations between family functioning and child psychological 
adjustment. Studies on CF were not reviewed in isolation, so it is unclear how family 
functioning interacts with CF specifically. Indeed, Drotar (1997) suggested that future 
research should explore whether family functioning interacts with adjustment 
differentially across health conditions. CF may be considered a particularly unique 
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condition in terms of its life-limiting and incurable nature, with demanding treatment 
regime. 
 
Leeman et al. (2016) conducted a meta-analysis exploring the relationship 
between family functioning and child wellbeing across a wide range of chronic 
conditions. To facilitate comparability, articles were included if one of four specified 
family measures was used. Broadly, Leeman et al. (2016) concluded that family 
functioning was related to child psychological wellbeing, particularly cohesion and 
conflict. Only one study on CF was identified (Szyndler et al., 2005). However, a range 
of measures of family functioning have been employed in studies of CF. Examples of 
measures used in CF studies include family support (Graetz, Shute & Sawyer, 2000) 
and parental coping (Wong & Heriot, 2008).  Knafl et al. (2015) critique that existing 
reviews on paediatric health conditions and the family often do not specify which family 
factors they will include, and so they developed a framework for how variables can be 
conceptualised. Understanding how family functioning variables interact with child 
mental health can potentially inform future systemic interventions. This is especially 
important as there remains limited evidence-based psychological treatments for those 
with CF and their families, particularly systemic interventions (Goldbeck et al., 2014). 
 
Rationale  
Previous reviews have included an aggregate group of paediatric health conditions, 
but this could potentially obscure the presence or absence of associations in CF 
specifically. Reviews by Drotar et al. (1997) and Leeman et al. (2016) have included 
children with a broad range of chronic health conditions, including diabetes, cancer, 
sickle cell disease, asthma, epilepsy and juvenile rheumatoid arthritis. However, CF is 
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a particularly unique chronic health condition in terms of its life-limiting nature, with 
particularly demanding daily treatment regime and lack of availability of face-to-face 
peer support. Although these reviews have been helpful in understanding the 
commonalities between various chronic health conditions, this could potentially 
obscure the presence or absence of associations in CF specifically. Indeed, the same 
family factors have been differentially related to different child mental health outcomes 
in diabetes and CF (Mullins et al., 1995). Understanding which family functioning 
factors are related to child mental health outcomes and in which direction, can guide 
assessment and intervention in families with CF. As such, the purpose of the present 
article is to consider family functioning in a broad sense, so that a systemic review of 
CF alone can be conducted. 
 
Objectives  
1. To summarise the literature on the association of family functioning and mental 
health in children with CF. 
2. To explore how family functioning has been measured. 
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Methods 
Eligibility Criteria  
Inclusion criteria: 
• Quantitative studies published in English-language peer-reviewed journals 
• Participants are children/adolescents (aged ≤18) with a diagnosis of CF and/or 
family member(s) 
• A family functioning variable must be measured and reported, guided by criteria 
developed by Knafl et al. (2015; appendix 1.2, page 88) 
• A child mental health variable must be measured and reported 
• A statistical association is made between the variables 
 
Exclusion criteria: 
• Reviews, dissertations, single case studies and conference abstracts 
• Qualitative methods 
• Intervention studies 
 
Information sources.  
1. The following databases were searched in June 2018: Medline (1946 – 2018), 
PsychINFO (1967-2018), EMBASE (1947-2018), CINAHL (1971-2018).  
2. Key journals were hand-searched. The Journal of Cystic Fibrosis was searched 
from its inception in 2002 until May 2018. All articles in the Journal of Pediatric 
Psychology containing the words “cystic fibrosis” were searched (1976 – June 
2018). 
3. References of included articles and other key studies were considered. 
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Search strategy. 
A university librarian was consulted for assistance in refining search terms. Full search 
terms for all databases are shown in appendix 1.3 (page 90). Variations of the following 
terms were used: 
1. Cystic fibrosis  
AND 
2. Parents or family or caregivers or mother or father or brother or sister 
AND 
3. Adjustment or adaptation or wellbeing or mental health or depression or 
anxiety or internalising or externalising or emotion or psychopathology or 
resilience 
AND 
4. Child or adolescent or paediatric or youth or young person/people or teen or 
infant 
 
Study selection. 
The process of study selection is outlined in Figure I. Search terms yielded 3356 
studies. Studies were gathered in EndNote and duplicates (n = 756) removed. Guided 
by eligibility criteria, 2600 titles and abstracts were screened for relevance; resulting 
in the removal of 2534 records. 66 full-text articles were accessed to determine 
eligibility. 40 articles were then removed, most frequently because a child mental 
health variable was not reported (n = 16). The remaining 26 articles were considered 
suitable for review and were assessed for quality (see below). Eleven articles were 
rated as poor quality and excluded from the final review, leaving 15 articles for 
inclusion in the quantitative synthesis. Articles by Thompson et al. (1992, 1994, 1999) 
10 
 
shared a cohort, as did those by Ward et al. (2009) and Sheehan et al. (2012; 2014), 
so they are considered as two studies. The review included 11 separate studies. 
 
Quality rating. 
A quality rating tool was developed (appendix 1.4, page 92) to standardise the 
appraisal process. A tool was developed as existing tools did not cover the range of 
factors most relevant to the type of studies included. The following guidelines were 
consulted in the development of the tool: SIGN 50 guidelines (2015), CONSORT 
guidelines (Boutron et al., 2008) and the STROBE Statement (von Elm et al., 2007). 
The tool was piloted and refined to ensure it captured the important features of 
included studies.   Points were awarded to studies for the abstract, rationale and 
objectives, description of participants, outcome measures, confounding variables, 
statistical analysis and discussion. A maximum of 36 points could be awarded, with 
total scores calculated as a percentage. Studies achieving fewer than 18 points were 
excluded from the review. A subset of four papers was co-rated by another researcher 
(trainee clinical psychologist), and any discrepancies in ratings discussed until 
agreement was reached. Studies were considered “good quality” if they achieved a 
rating of 80% or above, “moderate” if between 50% and 80% and “poor” if below 50%. 
The following 11 studies were rated below 50% and were therefore excluded: Cappelli 
et al. (1989), Cowen et al. (1985), Granvold, Woltman & Hocher(1990), Johnson et al. 
(1985), Kucia et al. (1979), Pumariega et al. (1993), Simmons et al. (1987), Stawski 
et al. (1997), Steinhausen & Schindler(1981), Steinhausen, Schindler & 
Stephan(1983) and Wilson et al. (1996).  Poor-quality studies were published between 
1979 and 1997, suggesting it would be unlikely that authors could be contacted for 
further information. Four authors of included studies (Sheehan et al., 2012, Smith et 
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al., 2010, Szyndler et al., 2005, Wong & Heriot, 2008) were contacted for further 
information on their reported results, for example, if correlations were available for 
subscales of measures. No responses were received, and this did not influence quality 
ratings. All included studies were rated as “moderate” quality; ratings are displayed in 
Table I. 
 
Data collection process. 
A data extraction tool (appendix 1.5, page 95) was developed to facilitate the process 
of identifying relevant information from articles.  
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Figure I. PRISMA flow diagram (Moher et al., 2009) of process for identification and 
inclusion of relevant studies 
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Results 
Table I summarises included studies.   
 
Study Characteristics 
Sample. 
Of the eleven studies with independent cohorts, 1740 children participated alongside 
1684 family members (all parent/caregivers). Of these, four studies examined 
adolescents (Graetz et al., 2000; Neri et al., 2016; Quittner et al. 2014; Szyndler et al., 
2005), three examined a wide age-range (7-17; Cappelli et al., 1988; Smith et al. 2010; 
Thompson et al., 1992,1994,1999), and two reported on younger children (aged 5-12: 
Wong & Heriot, 2008, aged 7-13: Mullins et al., 1995). The remaining studies followed 
up children from infancy (Goldberg et al., 1997; Sheehan et al., 2014).  
 
All but two studies (Neri et al., 2016, Quittner et al., 2014) reported on gender 
of the children included in the relevant analyses (n = 409), with 53.3% males and 
46.7% females. All studies except two included both the child and a family member 
(Graetz et al., 2000, Szyndler et al., 2005). For two studies, the gender split of the 
participating family members was not clear (Goldberg et al., 1997, Quittner et al., 
2014). Three of the studies included solely mothers (n = 112; Cappelli et al., 1988, 
Mullins et al., 1995 and Thompson et al., 1992,1994,1999). In the four remaining 
studies, including 404 family members; 72.8% were mothers, 27.0% were fathers and 
one person (0.002%) was a grandparent (Neri et al., 2016, Sheehan et al., 2014, Smith 
et al., 2010 and Wong & Heriot, 2008).   
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Six studies reported on disease severity (Sheehan et al., 2014, Smith et al., 
2010, Szyndler et al., 2005, Thomspon et al., 1992,1994,1999, Wong & Heriot, 2008). 
Four studies used objective medical measures such as mean forced expiratory volume 
in one second (Smith et al., 2010, Szyndler et al., 2005) and Schwachman-Kulczycki 
score (CF severity measure; Szyndler et al., 2005, Thompson et al., 1992,1994,1999). 
One reported on hospitalisations in the past year (Sheehan et al., 2014). Two 
described subjective ratings of disease severity from medics (Mullins et al., 1995) and 
family (Wong & Heriot, 2008).  
 
One study (Quittner et al., 2014) was conducted across eight European 
countries and the United States of America (USA). Neri et al. (2016) sampled Italian 
families in a multi-centre study. All other studies were conducted in circumscribed 
geographical areas in Australia (Sheehan et al., 2014, Wong & Heriot, 2008, Szyndler 
et al., 2005, Graetz et al., 2000), USA (Smith et al., 2010, Thompson et al., 1999, 
Mullins et al., 1995), and Canada (Goldberg et al., 1997, Cappelli et al., 1988).  
 
Design of studies. 
Studies followed observational, cross-sectional (n = 7) or prospective longitudinal 
designs (n = 2). Two studies reported on cross-sectional and longitudinal data. 
Recruitment was usually limited to one site, with small numbers of families sampled 
(Mdn = 50.0, range = 24-1286). An exception was the large international study by 
Quittner et al. (2014).  
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Table I: Summary of Included Articles 
Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
Neri et al. (2016) 
 
• Italy 
 
 
• 72% 
Observational 
cross-sectional 
survey. 
 
Explore impact 
of CF-related 
caregiving strain 
on occupational 
outcomes, and 
correlates of 
caregiver strain. 
 
211 
adolescents 
(aged 13-17) 
receiving 
treatment at 
one of 19 
CF centres, 
and a family 
caregiver.   
 
 
Child-
reported: 
SF-12 
Mental 
Component 
Summary 
(MCS)  
 
Caregiver 
reported: 
Proxy SF-12 
MCS 
Caregiver-
reported: 
Caregiver 
Burden Scale  
Spearman’s 
correlation 
 
 
Higher caregiver burden 
positively correlated with 
parent’s perception of 
adolescent’s mental health 
quality of life (QOL), but not 
with adolescent-reported 
QOL. 
 
 
Quittner et al. 
(2014)* 
 
• Belgium, 
Germany, 
Italy, Spain, 
Sweden, 
Netherlands, 
Turkey, USA, 
UK 
 
• 53% 
Observational 
cross-sectional 
survey. 
 
Explore levels of 
anxiety and 
depression and 
their 
concordance 
across parent-
adolescent 
dyads. 
1286 
adolescents 
(mean age 
14.84, SD = 
1.69) seen 
at one of 
154 CF 
centres, 
including 
1122 
adolescent-
Child-
reported: 
Hospital 
Anxiety and 
Depression 
Scale 
(HADS) 
 
And/orƗ 
 
Center for 
Epidemiol-
Caregiver-
reported: 
HADS 
 
And/orƗ  
 
CES-D 
Odds ratio Adolescents 2.32 Ɨ Ɨ times 
more likely to report 
elevated symptoms of 
depression if at least one 
parent did; 2.22 times more 
likely for anxiety. 
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Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
caregiver 
dyads.  
 
 
ogical 
Studies-
Depression 
scale (CES-
D) 
Sheehan et al. 
(2014)** 
 
• Australia  
 
 
• 78% 
 
 
Observational 
cross-sectional 
survey. 
 
Investigate 
caregiver coping 
strategies and 
association with 
child 
internalising and 
externalising 
behaviours. 
101 
caregivers of 
children 
(aged 3-8), 
being seen 
at one of 
three 
hospitals. 
 
 
Caregiver-
reported: 
Child 
Behaviour 
Checklist 
(CBCL)  
Caregiver-
reported:  
Brief COPE  
Adjusted 
logistic 
regression 
Proactive coping not 
related to CBCL. 
 
For each unit increase in 
avoidant coping, odds of a 
child experiencing clinically 
significant internalising 
behaviours increased by 
1.3. No relation to 
externalising. 
Sheehan et al. 
(2012)** 
 
• Australia 
 
 
• 56% 
Prospective 
cohort. 
 
Follow-up of 
Ward et al. 
(2009)* 
 
Determine 
prevalence of 
problem 
102 families 
of children 
(aged 3-8), 
being seen 
at one of 
three 
hospitals.  
 
 
Caregiver-
reported: 
CBCL (n = 
73) 
Caregiver-
reported: 
Questions 
measuring 
parenting 
warmth, 
consistency, 
overprotection 
from 
Longitudinal 
Adjusted 
logistic 
regression 
5.5% of children had 
persistent 
externalising/internalising 
behaviour over time. 
 
Low parenting warmth 
(only significant predictor at 
baseline) not a significant 
predictor of 
17 
 
Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
behaviours over 
time and identify 
predictors. 
 
Survey of 
Australian 
Children and 
National 
Longitudinal 
Survey of 
Children and 
Youth. 
 
Depression 
Anxiety Stress 
Scales 
internalising/externalising 
at three-year follow-up.  
 
 
Smith et al. 
(2010) 
 
• USA 
 
• 67% 
 
 
Observational, 
cross-sectional 
survey. 
 
Test hypotheses 
that families will 
report 
heightened 
depressive 
symptoms, be 
less adherent to 
lung clearance, 
and relationship 
insecurity will be 
associated with 
39 children 
(aged 7-17) 
being seen 
at one CF 
centre. 
 
 
Child-
reported: 
Children’s 
Depression 
Inventory 
(CDI)  
Child-
reported: 
Relatedness 
Questionnaire  
Independent 
t-test 
Children whose 
relationships with a parent 
were categorised as 
“insecure” had significantly 
higher levels of depressive 
symptoms than children in 
“secure” relationships. 
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Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
child depressive 
symptoms. 
Ward et al. 
(2009)** 
 
• Australia 
 
 
• 69% 
Observational 
cross-sectional 
survey. 
 
Determine 
prevalence of 
problem 
behaviours and 
association of 
child variables 
with parenting 
style. 
117 families 
of children 
(aged 6 
months – 5 
years old), 
being seen 
in one of 
three 
hospitals. 
 
 
Caregiver-
reported: 
CBCL (n = 
84)  
As Sheehan et 
al. (2012) 
Adjusted 
logistic 
regression 
 
 
Child four times as likely to 
experience elevated 
internalising/externalising if 
experiencing low warmth 
parenting. 
 
No significant relationships 
between 
externalising/internalising 
and inconsistency/over-
protection. 
  
 
Wong & Heriot 
(2008) 
 
• Australia  
 
• 61% 
 
Observational, 
cross-sectional 
survey. 
 
Examine 
vicarious hope, 
vicarious 
despair and 
coping 
strategies, and 
association with 
child variables.  
34 
caregivers of 
35 children 
(aged 5-12), 
attending a 
CF support 
group. 
 
 
Caregiver-
reported: 
Child Health 
Question-
naire: Parent 
Form 50 
(mental 
health 
subscale) 
 
Caregiver-
reported: 
Vicarious 
Futurity Scale  
 
Brief COPE 
 
 
Correlations 
 
Hierarchical 
regression 
 
 
Venting moderately 
correlated with better child 
mental health, and 
behavioural 
disengagement and self-
blame moderately negative 
correlated. Vicarious hope 
strongly positively 
correlated with better 
mental health and vicarious 
despair strongly negative 
correlated.  
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Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
High hope, low despair and 
lower self-blame all 
significant predictors of 
child mental health.  For 
each 1 unit in (improved) 
mental health, change of 
0.94 (hope), -0.82 (despair) 
and -4.31 (self-blame). 
Szyndler et al. 
(2005) 
 
• Australia 
 
• 58% 
 
 
Observational 
cross-sectional 
survey. 
 
Examine 
interrelationship 
of family 
functioning and 
psychological 
factors.  
52 
adolescents 
(12-18), 
attending 
one CF 
clinic. 
 
 
Child-
reported: 
Cystic 
Fibrosis 
Question-
naire (CFQ) 
 
Symptom 
Checklist-90-
Revised 
(SCL-90-R)  
 
 
Child-
reported: 
Family 
Environment 
Scale  
 
 
Spearman’s 
correlations 
Significant negative 
correlations between 
psychopathology and 
family cohesiveness 
(moderate), 
expressiveness (low) and 
organisation (moderate).   
 
No correlations with CFQ 
emotional functioning 
subscale. Moderate 
positive correlation of 
better body image with 
family cohesion, and 
moderately correlated with 
family conflict. 
Graetz, Shute & 
Sawyer (2000) 
 
Observational 
cross-sectional 
survey. 
35 
adolescents 
(aged 11-18) 
Child-
reported: 
Child-
reported: 
Multiple 
regression 
Internalising scores: total 
support from family and 
non-supportive behaviours 
20 
 
Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
• Australia  
 
• 53% 
 
 
 
Identify 
perception of 
supportive 
behaviours by 
family and 
friends and 
associations 
with 
psychological 
wellbeing. 
seen at one 
clinic. 
 
Youth Self 
Report Form  
 
 
Chronic 
Disease 
Support 
Interview 
 
 
significant predictors, 
accounting for 15% and 
24% of variance.  
Externalising scores: 
positive association with 
non-supportive family 
behaviours, accounting for 
26% of variance. 
Total scores: non-
supportive behaviours a 
significant predictor (25% 
of variance).  
Thomspon et al. 
(1999)*** 
 
• USA 
 
• 53% 
 
 
Prospective 
longitudinal 
survey. 
 
Explore stability 
and predictors 
of child 
adjustment. 
59 children 
(7-17), at 
one CF 
centre, and 
their 
mothers. 
 
 
Child-
reported: 
Child 
Assessment 
Schedule 
(CAS) 
 
Self-
Perception 
Profile for 
Children 
 
Mother-
reported: 
Mother-
reported: 
SCL-90-R – 
T1: anxiety 
and 
depression 
subscales; 
T2/T3: Global 
Severity Index 
ANOVA  
 
Hierarchical 
multiple 
regression 
T1, T2 and T3: no 
significant difference in T1 
maternal distress between 
children with stable good 
adjustment and children 
with stable poor 
adjustment.  
 
T1: mother’s anxiety added 
significant variance to 
child’s MCBC internalising 
(10%), externalising (16%), 
CAS total score (6%) after 
demographic variables and 
self-worth entered.  
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Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
Missouri 
Children’s 
Behavior 
Checklist 
(MCBC;  
children 
aged ≥14) 
 
T2: T2 maternal distress 
added significant variance 
(6%) to CAS total score 
after T1 CAS score 
entered.  
 
T3: no significant 
contribution of T1 maternal 
distress. 
Goldberg et al. 
(1997) 
 
• Canada 
 
 
• 58% 
Prospective 
longitudinal 
survey. 
 
To examine how 
early 
internalising 
problems can be 
predicted by 
health and 
psychosocial 
variables. 
Caregivers 
of 47 
children 
aged 1 at 
baseline, at 
one CF 
centre. 
 
 
Caregiver-
reported:  
CBCL at age 
4. 
Caregiver-
reported:  
Parenting 
Stress Index 
(PSI) 
Regression PSI best and most 
consistent predictor of total 
CBCL (13% variance at 
year 1, 15% at year 2, not 
significant at year 3) and 
internalising scores (9% 
variance at year 1, not 
significant at years 2/3).  
  
Mullins et al. 
(1995) 
 
• USA 
 
Observational 
cross-sectional 
survey. 
 
24 children 
(aged 7-13) 
and their 24 
mothers, 
Child-
reported: 
CDI 
 
Caregiver-
reported: 
Brief Symptom 
Inventory 
(BSI) – 
Hierarchical 
multiple 
regression 
BSI did not significantly 
predict child depressive 
symptoms/state anxiety. 
Maternal depression 
predicted significant 
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Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
• 56% 
 
 
Investigate 
patterns of 
adaptation and 
relationship 
between child 
and maternal 
adaptation.  
attending 
one hospital. 
State-Trait 
Anxiety 
Inventory for 
Children 
(STAIC) 
 
 
 
depression 
and anxiety 
subscales 
variance in child trait 
anxiety after physical 
health and demographic 
variables entered (39%).  
Higher depression 
predicted lower child 
anxiety.  
Cappelli et al. 
(1988) 
 
• Canada 
 
• 50% 
 
 
Observational 
cross-sectional 
survey. 
 
Exploration of 
interaction of 
disease with 
parental/family 
functioning on 
child’s 
psychosocial 
functioning.  
38 children 
(aged 7-16) 
and 29 
mothers, 
attending 
one CF 
clinic.   
 
 
Child-
reported: 
STAIC (aged 
7-13) or 
State-Trait 
Anxiety 
Inventory 
(STAI; aged 
13+)  
 
CDI 
 
Self-
Perception 
Profile for 
Children 
 
Mother-
rated: 
Caregiver-
reported: 
STAI 
 
Parental 
Bonding 
Instrument 
(PBI) 
 
Coping Health 
Inventory for 
Parents  
 
Impact on 
Family Scale 
(IFS) 
 
Block 
stepwise 
entry 
multiple 
regression  
Mothers’ trait anxiety a 
significant predictor of 
behavioural problems 
(43.1% of variance). 
Overprotective parenting 
accounted for further 
significant 8.2% of 
variance.  
Coping by understanding 
medical situation 
accounted for 14.4% of 
athletic self-esteem.  
IFS predicted 21.3% of 
variance for physical 
appearance self-esteem. 
 
No other significant 
associations. 
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Article  
 
• Location 
• Quality 
rating 
Design & aims Participants Measure of 
child mental 
health 
Measure of 
family 
functioning 
Data 
analysis 
Results 
CBCL  Family 
Functioning 
Index 
 
Ɨ Measures varied across countries; 56% used both. 
Ɨ Ɨ 2.32 is reported in the abstract and 2.39 in the results. 
*Besier & Goldbeck (2011) was excluded as this study presents the German results within Quittner et al. (2014). 
**Articles from the same cohort. Ward et al. (2009) features baseline data from 2007; Sheehan et al. (2012) report on follow-up 
data; Sheehan et al. (2014) report on cross-sectional data. 
*** Includes articles from the same cohort (Thompson et al., 1992, 1994). 
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Findings 
Measures of family system and parental functioning.  
As participating family members were always parent/caregivers, studies are divided 
into those utilising measures of family system functioning, and those measuring 
parental functioning. This is guided by criteria by Knafl et al. (2015) for conceptualising 
family variables. 
 
Family system functioning and mental health of children with CF. 
1. General family functioning. 
Two studies reported on general family functioning. Szyndler et al. (2005) reported 
significant negative correlations between adolescent-rated cohesion, expressiveness 
and organisation on the Family Environment Scale with an overall measure of 
adolescent-reported psychopathology (Symptom Checklist 90-R; SCL-90-R). 
Additionally, positive body image was positively correlated with cohesion and 
negatively correlated with conflict. Cappelli et al. (1988) used two measures of general 
family functioning; Family Functioning Index and Impact on Family Scale (IFS). IFS 
contributed a significant 21.3% of variance to physical appearance self-esteem, but 
no other associations were found between general family functioning and child mental 
health.   
 
2. Family processes: coping. 
Three studies reported on family coping. In the aforementioned study, Cappelli et al. 
(1988) also administered the Coping Health Inventory for Parents (CHIP). Coping by 
understanding the medical situation contributed a significant 14.4% of variance to 
athletic self-esteem. However, no other coping styles (i.e. maintaining family 
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integration and social support) were associated with mental health outcomes. 
Sheehan et al. (2014) administered the Brief COPE to assess proactive and avoidant 
caregiver coping. Child mental health was measured with the Child Behaviour 
Checklist (CBCL); a caregiver-reported measure of internalising and externalising 
behaviours. Each unit increase in avoidant coping increased the chances of a child 
experiencing clinically significant internalising difficulties by 1.3 times, with no effects 
on externalising. Wong and Heriot (2008) utilised the 14 coping style subscales of the 
Brief COPE, alongside the Vicarious Futurity Scale; a self-report measure of the 
hope/despair a parent has for their child’s future. Vicarious hope, vicarious despair 
and self-blame were significant predictors of a mental health subscale score. Hope 
predicted improved mental health, while despair and self-blame predicted higher 
distress.  
 
3. Family relationship quality. 
Two studies reported on the quality of family relationships. Smith et al. (2010) used 
the child-reported Relatedness Questionnaire to categorise parent-child relationships 
as either “secure” or “insecure”. Children who were characterised as insecurely 
attached to either parent had higher depressive symptoms, scoring marginally under 
the threshold for clinically-significant depression. Graetz et al. (2000) found that 
adolescents’ perceptions of family supportiveness significantly predicted internalising 
and externalising difficulties on the Youth Self Report Form. For internalising, 
supportiveness accounted for 15% of variance, and non-supportiveness 25% when 
combined support from family and friends was accounted for. Only non-
supportiveness significantly predicted variance in externalising (27% of variance) and 
total scores (25% of variance). 
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Parental functioning and mental health of children with CF. 
1. Parental mental health. 
Five studies reported on parental mental health. Quittner et al. (2014) administered 
parent-adolescent dyads a combination of the Hospital Anxiety and Depression Scale 
and Center for Epidemiological Studies Depression Scale. Adolescents were over two 
times as likely to report symptoms indicative of depression and anxiety if their parent 
also did. Thompson et al. (1992, 1994, 1999) examined maternal distress using the 
SCL-90-R. At baseline anxiety was a significant predictor of child externalising (10% 
of variance), internalising (16%) and child-reported mental health (6%). One year later, 
time 2 maternal distress similarly predicted 6% of variance in child-reported symptoms, 
controlling for time 1. Time 1 maternal distress did not predict variance at follow-up. 
Cappelli et al. (1988) found that maternal anxiety was a significant predictor of CBCL 
scores, accounting for 43.1% of the variance. Mullins et al. (1995) measured maternal 
anxiety and depression using a shortened version of the SCL-90-R. Maternal mental 
health did not predict child depressive symptoms or state anxiety, however, 
depression was a predictor of lower trait anxiety in the child (39% of variance). In a 
longitudinal study, Sheehan et al. (2012) found that caregiver mental health at baseline 
did not predict persistent internalising/externalising difficulties in children three years 
later. However, this calculation was likely underpowered.  
 
2. Parenting style. 
Two studies reported on parenting style. Parenting style was examined in one study 
using questions from national surveys (see Table I) measuring warmth, consistency 
and overprotection (Sheehan et al., 2012, Ward et al., 2009). At baseline, children 
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were four times more likely to experience internalising or externalising problems if they 
experienced parenting characterised by low warmth. No significant relationships were 
found with other parenting styles (Ward et al., 2009). Three years later 5.5% of children 
continued to experience internalising or externalising difficulties, with no parenting 
styles significantly predicting persistent problems (Sheehan et al., 2012). However, it 
appears that the analysis may have suffered from low power due to only four children 
having persistent mental health problems (of n = 73 with CBCL data). Cappelli et al. 
(1988) utilised the Parental Bonding Instrument to assess overprotection and care. 
Overprotection was a significant predictor of CBCL scores, accounting for 8.2% of the 
variance, with higher levels of overprotection predicting higher distress. 
 
3. Parenting stress. 
Two studies reported on parenting stress, finding mixed results. In a longitudinal study, 
Goldberg et al. (1997) measured CBCL scores at age four as an outcome. Parenting 
Stress Index scores at ages one and two predicted 13% and 15% of the respective 
variance in internalising/externalising at age four. At three years it was not significant. 
Neri et al. (2016) used the Caregiver Burden Scale, finding higher caregiver burden 
was positively correlated with parent-perceived mental health quality of life, but not 
associated with adolescent-reported. 
 
 
 
 
 
 
28 
 
 
Discussion 
 
The primary aims of this review were to examine whether family functioning is 
related to the mental health of children with CF and to explore how family functioning 
has been measured. Across all cross-sectional studies, significant findings were 
reported for at least one measure of family/parental functioning and child mental 
health, suggesting that less adaptive general family functioning, family coping, 
relationship quality, parental mental health and parenting style are related to poorer 
outcomes for children with CF. An exception is the study by Mullins et al. (1995) where 
maternal depression predicted lower child anxiety. Also, mixed associations were 
found for parenting stress, with Neri et al. (2016) finding a positive association between 
caregiver strain and parent-reported mental health quality of life in adolescents. In 
studies using regression methods, family functioning variables predicted levels of 
variance ranging from 6% (Thompson et al., 1992) to 43% (Cappelli et al., 1988). 
These variations may result, in part, from studies utilising a broad range of measures 
and methodologies. Overall findings are consistent with the meta-analysis of Leeman 
et al. (2016) who found that mental wellbeing was associated with family functioning 
across paediatric conditions. Similarly, literature reviews by Drotar (1997) and Berge 
& Patterson (2004) report consistent significant associations between family 
functioning and mental health in children across paediatric conditions, including CF. 
 
Conversely, in longitudinal studies parental functioning at baseline had 
diminishing effects on child mental health, until no longer significant. This contrasts 
with longitudinal studies on other health conditions, for example, Thompson et al. 
(2003) found that baseline family conflict increased the odds of having elevated CBCL 
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scores at nine-year follow-up in children with sickle cell disease. Consistent with this 
review, a meta-analysis has found that the strength of the relationship between 
maternal and child mental health in non-paediatric populations decreases into 
adolescence (Connell & Goodman, 2002). This could be related to mothers having 
less of an influence on children as they become older. 
 
Included studies which compared mental health difficulties in children with CF 
to control groups or normative samples found elevated levels of clinically-significant 
symptoms in the children with CF (Golderg et al., 1997, Quittner et al., 2014, Smith et 
al., 2010). One exception is the finding by Szyndler et al. (2005) that adolescents had 
lower levels of psychopathology than community samples. Similarly, Ward et al. (2009) 
found comparable levels of mental health difficulties with normative samples, but at 
three-year follow-up, internalising difficulties were significantly higher in the group with 
CF (Sheehan et al., 2012). On balance, evidence suggests that clinically-significant 
mental health difficulties are more common in children with CF, and therefore 
emphasises the importance of assessing these difficulties and providing timely 
psychological interventions. Furthermore, there is evidence of elevated psychological 
distress in adolescent-caregiver pairs (Quittner et al., 2014), suggesting the value of 
routine screening of both individuals with CF and caregivers (Quittner et al., 2016). 
However, research is needed to ascertain the best tools to do this (NICE, 2017). It 
could be helpful to extend routine screening to include measures of family/parent 
functioning across a range of factors and not just psychological distress. This would 
highlight if systemic or individual intervention is most appropriate to achieve the best 
outcome. Currently, there are limited evidence-based treatments for people with CF 
and their families. CF-specific interventions have tended to focus on treatment 
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adherence, with no evidence-based systemic interventions, or interventions targeted 
to family-caregiver wellbeing (Goldbeck et al., 2014). Evidence for interventions which 
target family/parent factors across paediatric conditions are in early stages, but there 
are promising results for treatments such as problem-solving therapy (Law et al., 
2014). Further evidence-based treatments for those with CF and their families are 
greatly needed to help improve quality of life, and to indirectly improve life expectancy 
by reducing factors associated with poorer treatment adherence, for example, child 
depressive symptoms and problematic family relationships (Smith et al., 2010). 
 
Limitations of Included Studies 
Family functioning was measured using a wide range of tools, however, many of the 
widely-used and validated tools available for measuring family functioning in paediatric 
populations were not utilised, for example, Family Assessment Device, Family 
Assessment Measure-III and Family Adaptability and Cohesion Evaluation Scale-IV 
(Alderfer et al., 2008). Ideally, family functioning would be captured by all members of 
the system, although this can be a practical challenge. Most often only one family 
member completed the family functioning measure, biasing results towards one 
viewpoint. Furthermore, most often the mother participated, with smaller subsets of 
fathers whose data sometimes had to be excluded due to low numbers. There are also 
problems associated with one family member completing all measures. Parents’ own 
wellbeing can influence their ratings of child behaviour (Treutler and Epkins, 2003). 
Poorer mental health could lead a parent to perceive the family as less functional. The 
perspective of another family member would help to test this hypothesis. Studies 
varied in whether measures were completed by the child, relative or both, hindering 
comparison across studies. 
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All tools used were self-reported, which brings several limitations, including 
socially desirable responding (van de Mortel, 2008).  Observational measures may 
help to strengthen research designs by offering an additional more objective 
perspective. Several observational tools have good reliability and validity in paediatric 
populations (Alderfer et al., 2008). However, utilising these in clinic settings, where 
most studies were conducted, may prove difficult.  
 
Limitations of Review 
The scope of the review was necessarily broad to allow only CF-related articles to be 
included. A broad age range was reviewed (0-18), which represents a heterogeneous 
group and CF and family factors may interact differentially across ages and 
developmental stages. The number of studies was limited due to the exclusion of 11 
low-quality articles. Most excluded articles reported significant associations between 
poorer family functioning and higher child distress with the exception of two (Kucia et 
al., 1979 reported on significant associations between better adjustment and 
maladaptive patterns of family functioning, and Simmons et al., 1987 found no 
significant associations for boys). Furthermore, generalisability has been limited by the 
nature of the studies; most had small samples which were recruited from one clinic. 
With the exception of Quittner et al. (2014) who recruited participants across nine 
countries, most studies were conducted solely in North America, Canada and 
Australia, with one in Italy. Potentially, the interaction of family functioning and child 
wellbeing may differ depending on the unique challenges of living in different countries 
(e.g. healthcare costs). This also limits generalisability to other countries not included 
in these studies, for example, the United Kingdom.  
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Conclusions 
All cross-sectional studies examining the association between family functioning 
variables with the mental health of children with CF have reported significant 
associations. In longitudinal research, family functioning variables have diminishing 
effects, and results for parenting stress are inconclusive. Notwithstanding, these 
results suggest that family functioning variables remain clinically relevant factors to 
consider, across a range of indices of family and parental functioning. Future research 
using observational measures and within larger populations may help to strengthen 
the evidence base and elucidate which family factors are the most potent indicators of 
child mental health difficulties. This will help to inform assessment of children and 
families, and the development of individual and systemic interventions to target 
problematic interactions within families. 
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Plain English Summary 
Title: Cystic fibrosis and family relationships: adolescent, parent and health-
professional perspectives 
Background 
Cystic fibrosis (CF) is a chronic and life-limiting health condition affecting mainly the 
lungs but also several other organs in the body. Recent improvements in the 
treatment of CF have meant that the average life expectancy has increased, with 
approximately half of people with CF living to 47. However, people with CF and their 
caregivers experience greater levels of anxiety and depression. Therefore, it is 
important that people with CF and their caregivers are well supported. There are 
times when support may be more important; for example, during stressful times such 
as adolescence, a time when there are many changes and an expectation for 
increasing independence. However, there are few studies exploring experiences of 
family relationships during this time.  
Aims  
The aim of the present study was to explore the experiences of family relationships 
during adolescence from the perspective of adolescents with CF, family caregivers 
and health-professionals working in CF services. 
Methods 
Eligible participants were approached by specialist nurses in CF services in two 
Scottish NHS health-boards. Participants were included if they were an adolescent 
with CF (aged 13-18), a caregiver of an adolescent with CF or a health-professional 
working in a CF service. Participants were not eligible to take part if they met any of 
the following: 
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• they had a learning disability or communication difficulties 
• were not fluent in English 
• participation would cause excessive distress  
Participants took part in an interview lasting approximately one hour. Interviews were 
audio-recorded, typed up and analysed for common themes in participants’ 
experiences.  
Main Findings and Conclusions 
Three adolescents, two mothers and two health-professionals took part. Interviews 
with participants resulted in three themes, each with two sub-themes. The first theme 
was family coping; sub-themes explored a tendency for coping with the demands of 
CF by not talking about it in day-to-day life, and experiences of accessing support 
inside and outside the family. A second theme explored roles and boundaries in 
families and how these might change during adolescence. A final theme explored 
how adolescents and parents manage balancing the goals of the family with the 
teen’s task of increasing independence during adolescence.  
As a small number of participants took part, it is not possible to say if these themes 
would be found in a larger population of people. However, results suggest that it is 
important to understand each individual family’s needs and offer extra support if 
required. This may be particularly important where families have little existing 
support to manage the challenges of CF and adolescence. It may also be helpful for 
teams to provide information and support on how families can have difficult 
conversations and manage relationship changes in adolescence.  
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Abstract 
Objective  
The aim of the present study was to explore the experiences of family relationships 
during adolescence from the perspective of adolescents with cystic fibrosis, family 
caregivers and health-professionals. 
Methods 
In-depth semi-structured interviews were conducted with three adolescents with cystic 
fibrosis (aged 15-18), two mothers and two health-professionals.  
Results  
Thematic analysis produced three themes, each with two sub-themes. Theme 1: family 
coping (using avoidant coping to manage the challenges of CF and the availability of 
support), theme 2: roles and boundaries (how these are adapted in families and the 
transition of these during adolescence), and theme 3: managing adolescence versus 
managing adolescents (adolescents balancing CF life with teen life and families 
balancing family and adolescent developmental tasks).  
Conclusions 
Although the sample was small, results suggest the importance that each individual 
family’s psychological needs are understood and appropriate support offered if 
required. Support to initiate difficult conversations and interventions aimed at the 
whole family may help to manage the psychological distress that can occur during 
stressful times such as adolescence.   
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Introduction 
 
Cystic fibrosis (CF) is a life-limiting and incurable genetic condition, affecting one in 
every 2500 births in the UK and 100,000 people worldwide (Cystic Fibrosis Trust, n.d.). 
Median life expectancy continues to rise and is currently 47 in the UK (Cystic Fibrosis 
Trust, 2017). Early detection through newborn screening, along with improvements in 
medical treatments have contributed to this. Additionally, future treatments are being 
investigated which target the genes implicated in CF and may hold promise in further 
improving life expectancy (Antoniou & Elston, 2016). Thus, there is growing need to 
meet the longer-term psychological needs of those with CF and their families.  
 
CF treatment involves a demanding and time-consuming daily schedule (Ziaian 
et al., 2006), which families have a role in supporting during childhood. CF can 
challenge the family system, with its uncertain nature and exacerbations which may 
require hospital admissions. Indeed, individuals with CF and their parents experience 
elevated levels of anxiety and depression (Quittner et al., 2014). Models of family 
coping, such as the Family Adjustment and Adaptation Response (FAAR) Model 
(Patterson, 1988) have outlined the challenge of maintaining stability within the system 
when the family is faced with stressful situations. In this model, the family must 
continually adjust itself to maintain stability, and family crisis may occur where 
demands outstrip available resources. In chronic health conditions, demands could 
represent an accumulation of daily strains (e.g. treatment regimens) or an acutely 
stressful event such as hospitalisation. Resources are drawn from individual members 
(e.g. personality traits), the family, or external sources (e.g. professional support). 
Family resources include the adaptive functioning of the family unit; for example, 
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cohesion, clear family structure and clear communication (Patterson, 1988). McClellan 
and Cohen (2007) reviewed quantitative evidence, finding mixed results as to if and 
how the presence of CF affects family functioning. Despite this, the nature of family 
relationships is predictive of both medical and emotional outcomes. DeLambo et al. 
(2004) found that a more positive observed family environment predicted improved 
adherence to lung treatments as reported by both young people with CF and their 
parents, but not enzymes, nutrition or antibiotics. Additionally, ability to balance the 
needs of the family with those of the young person has been shown to predict improved 
lung function (Patterson et al., 1993). Conversely, relationship strains between 
females and their parents predict poorer lung function (Patterson et al.,2009). Children 
with CF whose caregivers have avoidant coping styles have higher chances of 
experiencing clinically significant emotional difficulties (Sheehan et al., 2014).   
 
For a child with CF, adolescence is a particularly complex time where they will 
gradually take on more of the management of their condition, while sharing 
responsibility with caregivers (Drotar & Ievers, 1994). Adolescence is a stressful period 
characterised by multiple transitions, developmental tasks such as seeking identity 
and autonomy, and numerous biopsychosocial developmental changes; many of 
which are especially difficult to negotiate while managing a chronic health condition 
(Williams, Holmbeck & Greenley, 2002). Research suggests a decline in CF-treatment 
adherence during adolescence (Bishay & Sawicki, 2016), which may place further 
pressure on the family. Despite adolescence being a particularly unique 
developmental stage, in a review of CF and the family by Berge and Patterson (2004), 
there were very few studies featuring a solely adolescent sample. None of these 
studies were qualitative, except Graetz Shute and Sawyer’s (2000) mixed methods 
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study. Berge and Patterson (2004) argue for the addition of qualitative data to future 
research, and for the use of multiple perspectives when examining the complexity of 
family relationships. Cohen’s (1999) review suggests the importance of understanding 
paediatric chronic health conditions within the context of the family system, with 
studies demonstrating that family variables are stronger predictors of psychological 
outcomes than disease-related factors. 
 
To date, there has been a small pool of qualitative research exploring CF and 
the family. Phillips et al. (1985) explored the influence of CF on 43 families with a child 
aged up to twenty-one with a healthy sibling, from the parental perspective. They 
analysed responses to 62 potential problem areas in a semi-structured interview; with 
hospitalisation most frequently endorsed as a major problem. A third of mothers cited 
communication with the father as a significant difficulty. However, only 3% of fathers 
endorsed this. Using a grounded theory approach, Foster et al. (2001) explored 
themes within the topics of medical adherence and treatment of siblings, sampling 
eight children aged 10 to 18, eight siblings, eight mothers and a father. This multi-
perspective study found that CF could challenge family relationships, with both 
children with CF and parents describing that siblings garner less family attention, 
leading to a perception of siblings as resentful.  Furthermore, all parents described a 
continued role in medical management, even in late adolescence.  
 
In a mixed methods study of 35 adolescents, Graetz et al. (2000) carried out a 
qualitative coding of adolescent-reported behaviours, finding that non-supportive 
behaviours from family members predicted poorer psychological adjustment. 
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However, they only asked one question about non-supportive behaviours and did not 
consider the mechanisms by which this might happen. Barker et al. (2011) extended 
this by offering qualitative descriptions of why 24 adolescents rated behaviours as 
unsupportive. However, Barker et al. (2011), Graetz et al. (2000) and Phillips et al. 
(1985) used qualitative methods but limited the responses participants could give. 
Qualitative methods which utilise in-depth semi-structured interviewing allow for a 
more detailed exploration of personal experiences and therefore are well suited to 
exploring the complexities of relational interactions (Ganong & Coleman, 2014).  
Aims 
The aim of the present study is to explore experiences of family relationships during 
adolescence from multiple perspectives; those of adolescents with CF, family 
caregivers, and health-professionals working alongside these families.  
 
 
 
 
 
 
 
 
 
 
51 
 
 
Methods 
Design  
In-depth interviewing was employed to capture rich accounts of participants’ 
experiences. Thematic analysis was selected as the most appropriate method for 
analysing the dataset to provide a meaningful account of common themes across 
adolescents, mothers and health-professionals. Originally, it was planned that 
adolescents and family caregivers would be recruited, with a view to analysing data 
using Interpretative Phenomenological Analysis. Due to an unexpectedly high opt-out 
rate, a decision was made to recruit health-professionals also; details of which can be 
found in appendix 2.1 (page 97). As this increased heterogeneity of the sample, 
thematic analysis was used.  
Thematic analysis is a flexible approach, not bounded by any one particular theory 
(Braun & Clarke, 2006). As such, this makes it a versatile approach, with Braun and 
Clarke (2006) suggesting that researchers should therefore specify the approach 
taken to the analysis. The aim of the present study was to explore participants’ 
experiences and therefore an inductive approach was favoured to allow for themes to 
be identified from the data, independent of any pre-existing framework or theory. 
Generation of codes can be at both a semantic and latent level (Clarke & Braun, 2014), 
reflecting descriptive and more underlying meanings. This can help to gain an 
understanding of participants’ experiences and the meaning attached to them.  
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Participants 
Participants were adolescents (aged 13-18) attending CF services in either NHS 
Highland or NHS Greater Glasgow & Clyde (NHS GG&C), and/or a caregiver/parent, 
and health-professionals from these services. One member of the family could choose 
to participate without the other; if only a caregiver chose to participate, then it was 
ensured that the adolescent agreed to this. Type of caregiver was not restricted, as to 
allow for a variety of family structures. However, all caregivers recruited were mothers. 
Potential participants were deemed eligible for participation if they were able to give 
informed consent. To facilitate engagement in a spoken interview, only participants 
fluent in English were eligible. Exclusion criteria included a known learning disability, 
communication difficulties or acute psychological distress. In total, 23 of 25 families 
met eligibility criteria for participation.  
 
Procedure 
CF clinical nurse specialists provided all eligible families with a research pack 
including: a covering letter (appendix 2.2, page 100) and participant information sheets 
(PIS) (appendices 2.3 and 2.4, pages 101-106). Families sent back an opt-in form to 
consent to contact from the researcher or to opt-out of further contact. Health-
professionals were approached to determine their interest in participating and provided 
with a PIS (appendix 2.5, page 107). 
 
The researcher contacted interested individuals by email or phone to discuss 
the study in more detail, and then the interview was arranged if appropriate. Two 
53 
 
 
participants were interviewed in a clinic room at their respective hospital; one of whom 
was an inpatient. Three participants chose to be interviewed at home. Health- 
professionals were interviewed in clinic or by phone. Before each interview participants 
were informed of the limits of confidentiality and voluntary nature of their participation. 
The researcher answered any questions and then written consent was obtained 
(example consent/assent forms in appendix 2.6, pages 110-113). Consent was sought 
to send a letter to inform the adolescents’ general practitioner of their participation. 
Participants were also asked if they wished to receive a summary of the study’s results.   
 
Participants took part in a semi-structured interview lasting approximately an 
hour. Separate interview schedules were developed for adolescent, caregiver and 
health-professional participants (appendix 2.7, pages 114-120) which acted as a loose 
guide for the interviews. If a participant became distressed, they were offered a break 
and reminded that they could withdraw from the interview. Interviews were audio-
recorded and transcribed verbatim. Identifying information, such as names and places 
were removed prior to analysis to protect participant anonymity, and pseudonyms 
were given. Due to the small population of individuals with CF, gender references were 
also removed. Specific job titles are not provided to protect the anonymity of health-
professionals, however, both health-professionals were currently working with at least 
one of the adolescents and/or mothers. 
 
Data analysis 
The iterative process of analysing the interviews was guided by steps outlined by 
Braun and Clarke (2006). The first stage was to become familiar with the data by 
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engaging with it through transcription and repeatedly re-reading the interviews. Initial 
ideas were noted during this process. Following this, more detailed notes were made 
by reading the accounts line-by-line and assigning codes reflecting the meaning of 
small segments of data. All relevant ideas were coded for initially. Each transcript was 
analysed separately and then codes were interpreted together to identify broader 
patterns across participants. Provisional themes related to the research question were 
identified and then mapped and refined to ensure that each theme reflected a clear 
pattern in the data, based in participants’ accounts. The full data-set was then re-read 
to ensure that themes made sense in relation to the accounts, leading to further 
refinement of themes.  
 
Two transcripts were also analysed by two research supervisors with 
experience in qualitative methodology, to ensure that identified themes were similar. 
A third research supervisor read a draft of the results section to check that their 
interpretation of the themes was concordant with the researcher’s identified themes.  
 
Researcher reflexivity  
Braun and Clarke’s (2006) version of thematic analysis acknowledges that 
researchers will bring their own preconceived ideas to the analytic process and that 
themes do not simply “emerge” but are part of an active process between the 
researcher and the material. This fits with a critical realism stance which acknowledges 
that there is not an “accurate reality” to data (Clarke & Braun, 2014). Although themes 
will be driven by the content of the data within an inductive approach, it is important 
that the researcher is aware of their own biases which may be brought to the 
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interpretation of the data and that these are made transparent (Braun & Clarke, 2006). 
The researcher is a trainee clinical psychologist working within a paediatric clinical 
health psychology service, with an understanding of possible psychological effects of 
living with a chronic health condition, alongside knowledge of developmental, 
attachment and systemic models. Contact with the local CF service was avoided to 
minimise any bias from hearing about participants. Throughout analysis, the 
researcher remained aware of any assumptions and kept a reflective diary following 
interviews.  
 
Ethics 
The study was approved by the South East Scotland 01 Research Ethics Committee 
and sponsored by NHS Highland Research and Development department. Board 
approval was also granted by NHS GG&C (appendix 2.8, page 121-129). An 
amendment was also approved to recruit health-professionals (appendix 2.9, pages 
130-135). For participants under the age of 16, consent was obtained from both the 
adolescent and parent/caregiver, in line with Scottish Children’s Research Network 
guidance (ScotCRN, 2012).  
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Results 
Seven participants took part. Of the 23 families approached, five participants agreed 
to take part from four families. Two health-professionals, two mothers and three 
adolescents (aged 15-18) took part; one mother and one adolescent were related. 
Participants are listed in table I.  
 
Table I: Participant Roles and Pseudonyms 
Role Pseudonyms 
Adolescent with CF Ainsley 
Alex 
Jude 
Mother of adolescent with 
CF 
Isla 
Morag 
Health-professional working 
in CF team 
Jools 
Sam 
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Themes  
Themes are outlined in Table II. 
Table II: Themes and Sub-Themes 
Themes     Sub-themes 
• Family coping o Avoidant coping: We just don’t talk about it and it’s 
fine 
o Sources of support: Each jigsaw puzzle is 
different…it’s about helping them to create a full 
picture  
• Roles and 
boundaries 
o Adapted roles and boundaries: Have we let [them] do 
too much? 
o Transition of roles and boundaries in adolescence: 
Some do well with it, other people I guess struggle to 
find where they fit in that situation. 
• Managing 
adolescence 
versus managing 
adolescents 
o Teen life versus CF life: They just want to be normal 
o Family versus teen struggles: You’re trying to do it for 
their own sake…but you’re trying to let them grow as 
well 
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Theme 1: Family Coping. 
There’s not a day that goes by that CF is not…on your mind.    (Isla, mother, p. 
18) 
Since early in life, families have had to face the reality of having a child with a serious 
and life-limiting illness. Participants described the challenges and uncertainty of the 
diagnosis experience and first few years of life, providing a stressful context for early 
development. This will lead to families establishing ways of coping with the challenges 
of CF, for example, the practical burden of treatment regimes, appointments and 
hospitalisations, alongside the emotional impact of a progressive and life-limiting 
illness. By adolescence, it could be expected that families may have developed a 
pattern of coping with these challenges.  
Sub-theme 1: Avoidant coping  
We just don’t talk about it and it’s fine (Isla, mother, p. 28) 
Commonly, participants described a tendency for avoidant patterns of coping, 
potentially because this helps to minimise the impact of CF-related challenges on the 
family.  
 It never really comes up. (Morag, mother, p. 36) 
There may be varying functions to this avoidance, for example, maintaining a 
sense of normality.  
You just kinda plaster a smile on your face and kinda get on with it. (Alex, 
adolescent, p. 13) 
A lot of people when you tell them like you have a condition they automatically 
like have sympathy or like get worried because they think you’re ill but I don’t 
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like that because I don’t want people thinking that I’m like unwell or like ill. I just 
want them to know I’m a normal person like everyone else. (…) I just try to act 
like there’s nothing wrong with me.  (Ainsley, adolescent, p. 12) 
Participants described conversations about CF as infrequent, and when it was 
discussed, these tended to focus on the practical management of the illness and 
hopeful topics, such as cures. This suggests that the more emotional side tends to be 
hidden from conversation.  
Like there is sometimes we do talk about it but it’s not very often and if we do 
it’s like mostly just to do with like cures and all that, so it’s not really to do with 
me like physically or anything. (Ainsley, adolescent, p. 32/33) 
Holding on to the idea that the illness could one day be cured may help the 
family to maintain a sense of hope for the future. Participants also spoke of the 
distressing emotions that the presence of CF could elicit, for example, parental guilt at 
transmitting the CF gene, fear or sadness about shortened life expectancy and sibling 
resentment at the child with CF’s needs being prioritised.  
They [referring to parents] don’t y’know, want to sort of tell their child that almost 
[referring to genetic implications of CF] (…) because it’s as if they’ve failed them 
in some way.  (Jools, health-professional, p. 10) 
Avoidance of conversations may therefore act as a protective mechanism by 
defending family members from distressing emotions, with some participants 
describing this explicitly. Isla highlighted her ambivalent position of wishing to have 
sensitive discussions about CF but avoiding doing so for fear of the outcome. This was 
a particularly emotive reflection for Isla.   
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I’ve never ever said to [them] about dying with CF, I’ve never spoke to [them] 
about that. I just can’t bring myself to. But like you kind of want to say like all 
this medication is to help you live longer, y’know, if you don’t take the 
medication, you’re going to damage your insides even more (…) but I-I can’t 
bring myself to start that conversation with [them], it’s far too…hurtful for me. 
 (Isla, mother, p. 15) 
 Alex describes their mother as having an avoidant coping style and how this 
has influenced their relationship by placing distance between them.  
We’ve just never been close because of CF (…) she said that she can’t handle 
it.  (Alex, adolescent, p. 22)  
 Jude also links a pattern of avoidant coping by their mother with difficulties in 
their relationship, culminating in its eventual breakdown.  
I think it all just got too much for her and she didn’t really want to like cope with 
everything…herself anymore. ‘Cause like she did do it for a…long if you know 
what I mean. (…) I know it’s hard to like open up and talk to other people about 
it, but I wish she would do that. She’s not really that type of person.” 
 (Jude, adolescent, p. 33/34) 
Other more subtle forms of avoidance were apparent, e.g. providing 
reassurance and downplaying the severity of the illness. Again these could serve as 
protective strategies for managing the distress associated with the illness, however, it 
may preclude open discussion about CF, leaving questions unanswered. In Morag’s 
experience, reassurances may have comforted the adolescent in the short-term, but 
appears not to allay the teen’s fears in the longer-term as this cycle of reassurance 
continues. This is illustrated in Morag’s description: 
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That’s been the only time really that the CF was an issue for [adolescent] when 
people were saying that [you’re gonna die of CF soon] to [them] and 
[adolescent] was ‘oh what if I die?’ and I’m saying ‘you’re not going to die, 
[adolescent], you’re healthy’ y’know. I suppose the internet doesn’t help either, 
y’know like [they’ll] send me things people have gone through a double lung 
transplant and y’know you’ll see the photos and, ‘oh mum, what if I need that?’
 (Morag, mother, p. 17) 
Alongside parents using this coping style, adolescents may also avoid 
discussions to protect themselves and others. 
The child’s maybe frightened to ask the parents or frightened to bring it up in 
case they upset the parents (…) they know that that will upset their parents so 
they choose not to bring it up, it’s a kind of protective thing for them.       
(Jools, health-professional, p. 10) 
When you show you’re happy but you’re actually sad. It’s like you’ve got to 
kinda put a mask on. (Alex, adolescent, p. 12) 
 
Sub-theme 2: Sources of support 
Each jigsaw puzzle is different…it’s about helping them [the family] to create a 
full picture (Sam, health-professional, p. 22) 
Participants spoke about the availability of support for managing the challenges of CF. 
Over the course of life, there could be times when families require additional support 
to manage living with the challenges chronic illness can bring. This might be extra 
important during adolescence when there are extra challenges to navigate. For some 
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participants, family relationships allowed for the provision of this support. Ainsley 
reflected on their mother’s adjustment to CF, which they believed had allowed her to 
take on an emotionally-supportive role. 
She’s quite…supportive of like me anyway, but I feel like she’s came to terms 
with the CF as well.  (Ainsley, adolescent, p. 23) 
 Ainsley described family as a positive source of emotional support, in terms of 
motivating them to complete treatment. For Ainsley, professional support felt less 
needed.  
I think that’s actually what does give me the positive attitude as well ‘cause I’m 
not just doing it for like me, I’m doing it for my family as well.   (Ainsley, 
adolescent, p. 25) 
Similarly, although Jude’s relationship with their mother had broken down, they 
felt well-supported by other family members. Jude tended to view practical support, 
for example, reminders about treatment, as positive.  
…it doesn’t annoy me, it just shows me that [sibling] actually cares and must 
worry about it. (Jude, adolescent, p. 16) 
For others, external professional support was sought, with mixed experiences 
of accessing this. Morag reported a positive experience of accessing family and 
external support when needed. 
We do have good family support round about, and likes of [CF team-member], 
If there’s any issues I’ve just got to phone [them] and [they’re] on the case. 
 (Morag, mother, p. 7)  
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However, Isla described a process of seeking professional support but finding 
that these requests were not met.  
[CF team member 1] kind of said, asked me why I was getting upset. [Exhales] 
I ended up just having to – I lost it – y’know, started shouting at [them] ‘ why am 
I getting upset? Do you think this is what I want for my child?...blah, blah, blah, 
I’ve got no support.’ And I ended up, I just had to walk out. Em, [CF team 
member 2] came out looking for me and…there was still no support put in 
[laughs]. (Isla, mother, p. 16) 
Isla’s laughter contrasts with her sense of exasperation at the situation. Her 
sense of being unsupported was likely magnified by Isla’s report of difficulties 
accessing informal support within her own networks also, with a description that others 
“don’t understand” (p. 9). 
Participants commonly highlighted a lack of support for the wider family, 
namely, siblings. Unmet needs within the wider family was also echoed by those 
working in CF teams, with a description that teams are becoming more aware of these 
gaps in service provision.  
I feel like there should be like…more something like not just for CF patients but 
more something for their like sisters and brothers and that. (Jude, 
adolescent, p. 24) 
Support services are directed at the patient and at the families (…) the parents, 
but often the siblings are the bit of the jigsaw puzzle that’s forgotten about (…). 
I think as a CF service and teams, we’re becoming much more aware and 
wakening up to the fact that maybe we’ve got young people [referring to 
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siblings] who are struggling with the idea that (…) it’s a life-limiting illness.
 (Sam, health-professional, p. 7) 
Considering the previous theme about the unspoken nature of CF-related topics 
within the family, siblings therefore are likely to be unheard both in the family and wider 
network, placing them in a potentially lonely position. 
I think it impacts them too…like I dunno, they don’t really want to say it to you 
though. (Jude, adolescent, p. 15) 
 
 Theme 2: Roles and Boundaries. 
 Sub-theme 1: Adapted roles and boundaries. 
Have we let [them] do too much? (Isla, mother, p. 5) 
Participants described how CF could influence the family unit by positioning family 
members into adapted roles. From diagnosis, family members take on an additional 
role as a carer, assisting the child with intensive treatment regimes, such as 
physiotherapy and nebulised medications. For Morag, taking on this role resulted in 
her neglecting her own emotional needs and adjustment, possibly out of necessity 
during the early days of the illness, until these finally “hit” her (p. 44). She described a 
strong role as a protector, explaining that CF contributed to her relationship with her 
child becoming “too close” (p.49).  
[Child] was in and out of hospital and they finally diagnosed [them] and 
everybody collapsed, but I was the strong one because I had to learn about 
[their] medication, about [their] physio. And then, maybe a year down the line it 
hit me. (Morag, mother, p. 44) 
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 Participants spoke of a tendency for mothers to take on the carer role, attending 
hospital appointments and managing treatments.  
My mum was always here [hospital] with me, like here when I was sick (…) 
every time I’d be unwell like she would be here and like every time I had an 
operation she’d be there for me.   (Ainsley, adolescent, p. 19) 
It was never [father], it was always me. (Morag, mother, p. 59) 
For Jude, a sibling stepped into this role after the breakdown of their 
relationship with their mother. 
[They’re] always the one like ‘are you still taking it?’ like your medicine. (…) I 
guess [they’re] just trying to be the caring one. (Jude, adolescent, p. 16) 
Participants spoke about the role other family members found themselves in as 
the needs of the young person with CF were necessarily prioritised at times.  
Frequently, siblings were spoken about as being “pushed aside” (Jools, health-
professional, p. 14), possibly leading to a sense of their needs being subjugated in the 
family.  
My [sibling] would have to sit and watch a movie or something like that because 
mum would be too busy doing my medicines. (Jude, adolescent, p. 23) 
Siblings may find themselves in the position of adapting their needs in order to 
place less strain on the family unit, as Isla highlights below.  
I get on great with [sibling], [they are] just…lovely (…) but I think it’s because 
[sibling] is, [they don’t] want to give us any problems because we’ve enough 
with [adolescent].  (Isla, mother, p. 20) 
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Although Isla views this positively, for others, this can be problematic. In Alex’s 
experience, their sibling not conforming to “normal” role expectations was viewed as 
a difficulty for them.  
It’s like I kind of pave the way for the path myself, and a normal teenager like 
they kind of pave it for their younger [sibling]. (Alex, adolescent, p. 27) 
Alternatively, this could lead to a build-up of anger and resentment in the sibling 
which may manifest in ways which are more disruptive to relationships.   
I think the siblings as I say maybe show it in more negative ways (…). I definitely 
think siblings sometimes get angry and resentful of the child with CF for the 
attention they get (…). When you actually sometimes get y’know kind of get 
them [parent] to think about it, it’s actually because the sibling’s craving 
attention or just wanting acknowledgement.  (Jools, health-professional, p. 
15/16) 
Morag reports that the closeness of her and the adolescent had resulted in 
distance with her partner. 
I would always take [child’s] side y’know, and I think [father] did feel pushed 
out by that.   (Morag, mother, p. 49) 
Mothers and health-professionals described a fluidity in boundaries for the 
adolescent with CF, driven by a sense of parental guilt about transmitting the CF-gene.  
I felt sorry for [child], I think well [they’ve] got an illness, leave [them] alone. 
 (Morag, mother, p. 50)  
I feel guilty and I think…[adolescent] knows [laughs]. [Adolescent] knows how 
to play you as well, y’know, I mean I don’t spoil [adolescent] loads but 
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[adolescent] does get a lot more than what a normal teenager would get 
because I do feel guilty.     (Isla, mother, p. 19) 
Mothers expressed uncertainty about their style of parenting. Isla also 
wondered if fear for the future contributed to the flexibility of boundaries. In the 
following quote, Isla’s distress is exemplified by her difficulty in labelling the unspoken 
content of her fears. 
Y’know, is [adolescent] too spoilt? (…) are we giving [them] too much because 
I’m scared…is [adolescent] going to be here for –do you know what I mean?
 (Isla, mother, p. 5/6) 
 
Sub-theme 2: Transitioning of roles and boundaries in adolescence. 
Maybe it is a loss of a role (…) some do well with it, other people I guess 
struggle to find where they fit in that situation. (Sam, health-professional, p. 
4) 
During adolescence it would be expected that roles and boundaries start to shift as 
adolescents begin to develop their own sense of individuation from the family. Health-
professionals described the desired shift in boundaries; a gradual change, which they 
would attempt to model in clinic. 
We’d be trying to get the mum to become much more of a supportive role as 
opposed to that carer role (…) where they’re coming alongside the young 
person. (Sam, health-professional, p. 17) 
For some participants, the movement of boundaries had been more 
successfully negotiated. Morag had described her relationship as “too close” with the 
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adolescent, with her partner feeling “pushed out” (p. 49), but this had improved as she 
gradually reduced her involvement over adolescence and became more able to 
enforce discipline.  
I’ve backed off from [adolescent] and let [them] do [their] own thing so maybe 
that’s improved their relationship too because I’m not all for [adolescent] (…) 
whereas now I’ll give [child] a row because [adolescent’s] older now (…) [father] 
probably feels well y’know we’re more on the same page.  (Morag, mother, 
p. 58)  
 For Isla, movement of roles and boundaries was less straight-forward, and was 
possibly inhibited by family avoidance and conflict.  
If any of that’s [referring to treatment]…mentioned, [they] get annoyed, em, and 
then I start saying you know ‘this is for your own good we’re telling you, blah, 
blah, blah’ and then…it just escalates into a row.  (Isla, mother, p. 28) 
On the other hand, Jude was “thrown in the deep end” (p. 39) when their 
mother’s role as a carer suddenly changed in adolescence, leading to them attending 
clinics on their own at an early age. Jude expressed this statement in a quiet voice, 
possibly reflecting a sense of loss, shame or guilt at the situation: 
Em…I don’t really know why I went to clinic myself but…I guess that was like 
to do with like my mum or whatever I think. It’s…I guess like everybody’s 
relationship’s different, but I don’t really have a strong relationship with my 
mum. (Jude, adolescent, p. 28) 
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Theme 3: Managing Adolescence Versus Managing Adolescents. 
You’ve got to live your kid’s life. (Alex, adolescent, p. 7) 
Participants described the difficult task of managing family developmental tasks 
during adolescence (balancing the adolescent’s involvement in the system with 
spending increasing time away from the family), alongside adolescents meeting their 
individual developmental needs, such as seeking their own sense of identity and 
individuation from the family. The management of these developmental tasks during 
adolescence can pose particular additional challenges within the context of a chronic 
health condition. Participants described a sense of internal struggle for adolescents as 
they balance CF life with teen life. This could then be reflected in the wider system as 
a struggle between family and individual developmental tasks.  
Sub-theme 1: CF Life versus Teen Life. 
 They just want to be normal. (Jools, health-professional, p. 20) 
Participants described a sense of an internal struggle within the adolescent as they 
negotiated CF life with maintaining a normal adolescence. Jude describes focusing on 
the present, which could be a feature of the adolescent mind-set which tends to be 
more here-and-now focused. It may also be a protective strategy to avoid the 
consideration of possible future outcomes. Adolescents may also have many other 
competing priorities to consider, such as school and extra-curricular activities. 
I think that I’m healthy enough right now so…that’s it really. I’ll just come to it 
once it came to it if you know what I mean.  (Jude, adolescent, p. 
36) 
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I get more stressed about school than I do about my actual like CF. (Ainsley, 
adolescent, p. 7) 
Alex described the ambivalent position of trying to live a “normal” teenage life 
(p. 8) alongside CF and having to “fight” for independence (p. 27). They highlight the 
frustration of this experience: 
It’s also a bit frustrating because you don’t get to do stuff with your peers. As 
well, I’m not allowed to do the normal teenager things like going out drinking 
and all that, ‘cause like mixing medication’s not allowed and it’s frustrating, 
especially when you’re a teenager with CF because it’s like you don’t get to like 
test certain things out. (Alex, adolescent, p. 8) 
Ainsley described how their family recognised the internal struggle CF could 
create, and so sought to minimise this in order for them to feel “normal”. This links 
back to the first theme, suggesting that a possible function of avoidance of discussions 
is to maintain normalcy.   
Talking about it all the time that makes me feel like I’m not the same as 
everyone else, so I think they just kind of like try to treat me like just everyone 
else and just like not talk about it that much. (Ainsley, adolescent, p. 32) 
 
Sub-theme 2: Family Versus Teen Struggles. 
You’re trying to do it for [their] own sake…but you’re trying to let [them] grow as 
well.  (Isla, mother, p. 28) 
Adolescence is a normatively stressful time for young people as they navigate various 
developmental tasks in the context of biopsychosocial changes and life transitions, but 
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CF can pose additional challenges in terms of a “battle” (Jools, health-professional, p. 
1) for control between parents and adolescents. This could arise from the different 
priorities of adolescents and parents, with parents keen to maintain consistent regimes 
to protect their health, but teens focusing on here-and-now priorities such as friends 
and school.  
They’re only thinking about the here and now, right now, yeah, whereas we’re 
thinking about the long-term effects, if you stop doing these treatments, that’ll 
cause damage, then that’ll impact on your life expectancy. Whereas they’re 
thinking ‘oh not right now, I don’t need to worry about that, that’s a long way 
away.’  (Sam, health-professional, p. 14) 
Just kinda seeing that [treatment routine] kinda almost fall apart sometimes is 
just too much for the parents. They want to have that control because they know 
that that control is almost what’s kept the child well for so long. (Jools, health-
professional, p. 5) 
Navigating the usual developmental tasks of the individual and family is 
complicated by the presence of a chronic illness. At a time when adolescents are 
seeking increased responsibility, they also retain a heightened sense of reliance on 
their family as compared with healthy peers, in terms of the support required for 
hospital appointments and treatment. Participants described a sense of fear about 
family support being reduced, even in those adolescents who considered themselves 
independent in the management of their condition. 
And [they’ll] be ‘oh what happens if I have to get IVs [intravenous anti-biotics] 
you won’t be able to stay in the hospital with me’ that’s [their] main thing. 
 (Morag, mother, p. 55) 
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I know that my mum’s not there to do everything anymore and I think that makes 
me more nervous. (Ainsley, adolescent, p. 30) 
 For Isla, there is a conflict between allowing the adolescent to become more 
independent and the provision of the support that she feels the young person needs. 
Isla describes this as a losing battle: “you can’t win” (p. 14). 
[They’re] wanting to be more adult about it but [they’re] not mature enough, in 
my opinion. (Isla, mother, p. 14)  
A level of rebellion and struggling against the family would be considered 
normative during the adolescent period. Again, chronic illness could complicate this 
process, with non-adherence to treatments becoming a vehicle for rebellion.    
Sometimes the young person just feels the parent is constantly nagging them 
or constantly on their case to do things and it is just a bit of rebellion y’know 
and sometimes it’s the thing they know they can rebel with is their treatment 
because it sometimes is the thing that will upset their parents the most.
 (Jools, health-professional, p. 4) 
For other families, this struggle may be minimised. Where participants reported 
positive family relationships, reciprocation of responsibility between parent and 
adolescent, or a routine for illness-management; conflict tended to be minimised. 
Referring to treatment management, Sam gives an example of what works well: 
It’s just part of the, a natural kind of occurrence as opposed to it being a big 
event (…) it becomes part of the routine.  (Sam, health-professional, p. 
25) 
My mum is literally like one of my best friends. (Ainsley, adolescent, p. 19) 
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Linking back to the first theme, avoidant coping and unspoken emotions may 
also intensify the struggles of adolescence.  
You’ve kind of got an end-stage disease idea in your head but that’s way out 
there but when your young person starts challenging and not wanting to do their 
treatments you worry that that time is going to come in and be shorter (…) 
parents can really struggle with that and something what’s their fear then 
becomes anger and it leads to conflict. (Sam, health-professional, p. 12) 
Sometimes you’ll bottle them up, and sometimes you’ll just kinda get on with it. 
But sometimes you’ll have a big lash out and a screaming match. (Alex, 
adolescent, p. 9) 
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Discussion 
The present study sought to understand experiences of CF and family relationships 
during adolescence from the perspective of adolescents, mothers and health-
professionals. The interplay of family factors with chronic health conditions has been 
extensively studied, however, quantitative research has been limited in exploring the 
more complex nature of how family relationships are experienced and how this may 
interact with CF at different developmental stages (Berge & Patterson, 2004). The 
present study adds to the literature by exploring the relational experiences of 
adolescents with CF, mothers, and health-professionals working closely with families.  
 
The FAAR model (Patterson, 1988) suggests that families are in a constant 
dynamic of trying to maintain stability in the face of challenges to the family system, 
including the demands of chronic illness. Furthermore, managing chronic illness during 
adolescence places further pressures on the family (Rolland, 1987). Participants 
commonly described a tendency not to discuss CF. During adolescence, it would be 
expected that distance between family members increases as the adolescent seeks 
individuation (Combrinck-Graham, 1985) and this could explain why conversations 
may be less frequent. However, in the descriptions given by participants, it appears 
that the avoidance described serves a protective function. Not discussing CF regularly 
may allow the adolescent and family to create a sense of normalcy and echoes 
previous qualitative research on CF which has found “normalisation” to be a prominent 
coping strategy for families during the transition period (Dupuis, Duhamel & Gendron, 
2011). Avoidance of discussions appeared to be a two-way process, and findings are 
consistent with a small qualitative exploratory study which found that most young 
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adults found out about life expectancy from their doctor rather than their family, and 
many wished to shield their parents from the emotional distress that such discussions 
could cause (Farber et al., 2018). Although protective, at other times this strategy may 
preclude open discussion around important topics, leaving questions unanswered for 
adolescents and family.  
 
Dealing with the stress of a chronic illness meant that family members were 
required to adapt their normal roles, for example, siblings were described as missing 
out. In their grounded theory study, Foster et al. (2001) similarly reported on a 
perception that siblings experience resentment at the needs of children with CF 
appearing prioritised. In the current study, participants described a tendency for 
mothers to take on a carer role, for example, in accompanying the child to 
appointments and administering treatments. Indeed, Hodginson & Lester (2002) found 
that all of seventeen mothers interviewed about their experiences of caring for a 
younger child with CF experienced their role as stressful, including the heightened 
sense of responsibility that they held. Berge and Holm (2007) posit that for families of 
children with a chronic condition, the uncertainty and challenges this poses can lead 
to “boundary ambiguity” where there is uncertainty around roles within the family; for 
example, uncertain expectations for the child’s behaviour. Ambiguity may place extra 
strain on navigating role and boundary changes during adolescence. Where 
caregivers experience uncertainty and stress, this can reduce personal and family 
resources to manage the challenges of stressful times. Also, if a parent is experiencing 
distress, then it is more likely the adolescent will too (Quittner et al., 2014). 
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Participants described the challenges of adolescence, in terms of negotiating 
the balance between adolescents completing their individual developmental tasks, 
alongside family developmental tasks. Transition of CF care is a complex process 
influenced by many factors, including parental, child and family factors (Leeman et al., 
2015). Difficulties might arise where there is a mismatch between the family conferring 
responsibility to the adolescent, and the teen’s ability or willingness to take on greater 
responsibility. For some families, where this balance is negotiated, additional 
difficulties may be minimised. However, for others this could increase the burden of 
CF, causing a struggle between parent and adolescent. Parent-teen interactions have 
been listed by adolescents with CF and their caregivers as one of their top three most 
problematic situations in a structured interview (DiGirolamo et al., 1997). It is important 
that conflict in relationships with caregivers is minimised as far as possible. Family 
difficulties, for example relationship strains, can have negative implications for 
treatment adherence and physical health (DeLambo et al., 2004, Patterson et al., 
1993, 2009). As such, it is of great importance that family needs are monitored, and 
appropriate support offered to proactively reduce stress, prevent ruptures in the family 
and indirectly influence physical health outcomes. Assessing family needs could be 
challenging at a time when adolescents are encouraged to attend clinics on their own 
and suggests that it may be important for parents and teens to have time alone to 
discuss any difficulties. Indeed, this is particularly important considering results that 
adolescents and parents may tend not to discuss CF, sometimes due to the distress 
it may cause to themselves or others. 
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Strengths and Limitations 
A strength of this study was the attempt to gather multiple perspectives regarding 
family experiences. However, a major limitation of this study was the small sample 
size, despite efforts to recruit a larger sample. Furthermore, participants were a 
heterogenous group, with varying roles, family backgrounds and structures. As such, 
participants are therefore not necessarily representative of the wider CF population. 
With a small sample size, it is possible that data saturation was not reached and that 
the themes may not be replicated in a larger sample. However, participants shared 
very emotive experiences on topics such as family breakdown and the life-limiting 
nature of CF which provided in-depth accounts.  
 
Clinical Implications 
Adolescence is a particularly complex time, especially in the context of a chronic and 
life-limiting health condition. Although the results are limited in their generalisability, 
they suggest that supporting the family during this time is of great importance, where 
needed. Some participants spoke of a difficultly in initiating CF-related conversations. 
Support in clinic could be augmented with the provision of resources for parents and 
adolescents to consider how they might approach difficult conversations. Furthermore, 
this highlights the importance of both adolescents, their carers and siblings having a 
safe space to explore emotions. Currently, there is a lack of evidence-based 
interventions to provide support for people with CF and their families (Goldbeck et al., 
2014) and so new treatments are greatly needed. It may be particularly important for 
families to access professional support if resources are lacking within their existing 
networks; potential service development could include the provision of support groups 
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for caregivers and siblings; or information on maintaining relationships during 
adolescence. NICE (2017) guidelines advise that the emotional needs of the individual 
and family should be assessed at critical time points such as transition. The use of 
screening tools may help to quickly identify families who are experiencing difficulties 
at an early stage.  
 
Future Research 
Due to the small sample size, future research could replicate the study with a larger 
sample size to ascertain if the same themes are present in a more representative 
group. As recruitment of participants was difficult, it would be important to consider 
how to engage families in such research. Furthermore, carrying out interviews with 
other family members, for example, fathers and siblings, could provide more 
comprehensive data on experiences of relationships within a system. 
 
Conclusion 
The present study sought to explore experiences of CF and family relationships during 
adolescence from multiple perspectives. It is important that each individual’s and their 
family’s psychological needs are understood, and appropriate support offered, to 
promote well-being and reduce psychological distress. This may then positively 
influence treatment adherence and ultimately improve physical health.   
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Appendices: Chapter 1 
Appendix 1.1: Author guidelines for the Journal of Pediatric Psychology 
Organization of manuscripts 
Manuscript Central will guide authors through the submission steps, including: 
Abstract, Keyword selection, and the Manuscript. The manuscript must contain an 
Introduction, Methods, Results, Discussion, Acknowledgements and Reference List. 
Length of manuscript: Original research articles should not exceed 25 pages, in total, 
including title page, references, figures, tables, etc. In the case of papers that report 
on multiple studies or those with methodologies that necessitate detailed 
explanation, the authors should justify longer manuscript length to the Editor in the 
cover letter. Case reports should not exceed 20 pages. Review articles should not 
exceed 30 pages. Invited commentaries should be discussed with the Editor. 
The Journal of Pediatric Psychology no longer accepts brief reports but will accept 
manuscripts that are shorter in length than the 25 page manuscript. 
Manuscripts (text, references, tables, figures, etc.) should be prepared in detailed 
accord with the Publication Manual of the American Psychological Association (6th 
ed.). There are two exceptions: 
The academic degrees of authors should be placed on the title page following their 
names, and a structured abstract of not more than 250 words should be included. 
The abstract should include the following parts: 
1. Objective (brief statement of the purpose of the study);  
2. Methods (summary of the participants, design, measures, procedure);   
3. Results (the primary findings of this work); and  
4.  Conclusions (statement of implications of these data). 
Key words should be included, consistent with APA style. Submissions should be 
double-spaced throughout, with margins of at least 1 inch and font size of 12 points 
(or 26 lines per page, 12-15 characters per inch). Authors should remove all 
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identifying information from the body of the manuscript so that peer reviewers will be 
unable to recognize the authors and their affiliations. 
Informed consent and ethical treatment of study participants: Authors should indicate 
in the Method section of relevant manuscripts how informed consent was obtained 
and report the approval of the study by the appropriate Institutional Review Board(s). 
Authors will also be asked to sign a statement, provided by the Editor that they have 
complied with the American Psychological Association Ethical Principles with regard 
to the treatment of their sample. 
Clinical relevance of the research should be incorporated into the manuscripts. 
There is no special section on clinical implications, but authors should integrate 
implications for practice, as appropriate, into papers. 
Terminology should be sensitive to the individual who has a disease or disability. 
The Editors endorse the concept of "people first, not their disability." Terminology 
should reflect the "person with a disability" (e.g., children with diabetes, persons with 
HIV infection, families of children with cancer) rather than the condition as an 
adjective (e.g., diabetic children, HIV patients, cancer families). Nonsexist language 
should be used. 
Special Instructions for Types of Manuscripts 
• Systematic reviews 
 (b) Systematic reviews: Systematic reviews should not exceed 30 pages. Authors 
are required to attach the PRISMA checklist and flow diagram as supplementary 
material for each submission. Authors can find the PRISMA checklist and flow 
diagram in downloadable templates that can be re-used here. Authors of systematic 
reviews that do not include a meta-analysis must provide a clear statement in the 
manuscript explaining why such an analysis is not included for all or relevant 
portions of the report. 
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Appendix 1.2: Conceptualisation of Family Functioning 
Knafl et al. (2015) provide a framework for conceptualising family variables in research 
on paediatric health conditions within families. The authors distinguish between family 
system functioning variables (defined as family relationships, structure, processes, 
characteristics and resources) and family member functioning (defined as wellbeing, 
experiences and ability to carry out role, e.g. parenting style and stress). For the 
purposes of this review, family and parental functioning was separated according to 
these criteria:  
 
Study Family variable measured Knafl et al. (2015) category 
Neri et al.(2016) Caregiver burden Parental functioning 
(performance of parenting role) 
Quittner et al. 
(2014) 
Parental depression and 
anxiety 
Parental functioning (wellbeing) 
Sheehan et al. 
(2014) 
Coping Family system functioning 
(family processes, e.g. coping) 
Sheehan et al. 
(2012) 
Parenting style  
 
Parental functioning 
(performance of parenting role 
and wellbeing) 
Smith et al. 
(2010) 
Security of relationships Family system functioning 
(family relationships) 
Ward et al. 
(2009) 
Parenting style  Parental functioning 
(performance of parenting role) 
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Wong & Heriot 
(2008) 
Coping Family system functioning 
(family processes, e.g. coping) 
Szyndler et al. 
(2005) 
Family environment Family system functioning 
(family system characteristics) 
Graetz et al. 
(2000) 
Perceived supportiveness Family system functioning 
(family resources) 
Thompson et al. 
(1992, 1994, 
1999) 
Maternal mental health Parental functioning (wellbeing) 
Goldberg et al. 
(1997) 
Parenting stress  Parental functioning 
(performance of parenting role) 
Mullins et al. 
(1995) 
Maternal mental health Parental functioning (wellbeing) 
Cappelli et al. 
(1988) 
Maternal anxiety 
 
 
Parental functioning (wellbeing) 
Relationship quality 
Coping 
Impact on family 
Family system functioning 
(family relationships, processes 
and resources) 
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Appendix 1.3: Search strategy 
Database Search terms used 
CINAHL 
Medline 
PsychoINFO 
Major subject heading (MM) cystic fibrosis OR cystic fibrosis or CF 
 
AND 
 
MM relating to parents, family, caregivers OR mother* or father* or 
brother* or sister* or carer* of caregiver* or care giver* or parent* 
or family 
 
AND 
Subjects (DE): adjustment or DE emotional adjustment OR MM 
relating to emotions OR adjustment or adaptation or well#being or 
mental health or depression or anxiety or internali?ing or 
externali?ing or emotion* or psychopathology or resilience OR MM 
relating to psychopathology/adolescent psychopathology/child 
psychopathology  
 
AND  
 
Mm relating to child* or adolesc* or p#ediatric or youth or young 
person* or young people or teen* or infant* 
 
EMBASE Exp cystic fibrosis OR (cystic fibrosis or CF).mp 
 
AND 
 
Exp parent or exp family or EXP caregiver or (mother* or father* or 
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 brother* or sister* or carer* or caregiver* or care giver* or parent*  
 
or famil*).mp  
 
AND 
 
Exp psychological adjustment or exp emotion or exp psychological 
  
resilience or mental health or (adjustment or adaptation or  
 
well?being or mental health or depression or anxiety or  
 
internali#ing or externali#ing or emotion* or psychopathology or  
 
resilience).mp 
 
AND 
 
Exp juvenile or (child* or adolesc* or p?ediatric or youth or young  
 
person* or young people or teen* or infant*).mp 
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Appendix 1.4: Quality rating tool 
 
Abstract  The abstract provides a 
summary of the study including 
methods and results. 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
Introduction  
 
Provides scientific background 
and justification for study. 
 
 
 
 
2- Well covered and 
justified 
1 – Adequately 
covered and 
justified 
0 – Not/poorly 
covered and 
justified 
 
 
Provides 
objectives/hypotheses. 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
 
Methods  
• Design 
 
 
 
 
Clearly states study design. 
 
 
 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
• Participants Justification for sample size. 
 
 
 
 
 
 
 
 
 
 
 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
Inclusion/exclusion criteria 
stated. 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
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Settings and locations and 
dates for data collection 
outlined. 
 
2 – Well covered 
1 – 
Adequately/partly 
covered 
0 – Poorly/not 
covered 
Participant characteristics 
clearly described and 
representative of target 
population. 
 
2 – Well covered 
and considered 
representative 
1 – Covered but not 
considered 
representative/partly 
covered 
0 – Not covered 
• Outcomes All of the outcomes are clearly 
described. 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
 Measure of child/adolescent 
mental health is appropriate. 
 
2- Standardised 
tools with reported 
validity/reliability  
1 – Standardised 
tools but no report 
of validity/reliability 
or low 
validity/reliability 
0 – Non- 
standardised 
assessment 
 Measure of family functioning 
is appropriate. 
 
2- Standardised 
tools with reported 
validity/reliability  
1 – Standardised 
tools but no report 
of validity/reliability 
or low 
validity/reliability 
0 – Non- 
standardised 
assessment 
 Confounding variables have 
been reported and taken into 
account. 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
Statistical analysis Numbers given for each group 
analysed and non-participation 
described. 
 
2 – Well covered 
1 – Adequately 
covered 
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0 – Poorly/not 
covered 
Statistical methods are 
appropriate. 
 
2- Appropriate 
1 – Adequate 
0 – Not appropriate 
Findings are clearly described. 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
Where appropriate confidence 
intervals are reported. 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
• Discussion Limitations of study are clearly 
described, taking into account 
potential sources of bias. 
 
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
Generalisability of study is 
clearly described.  
2 – Well covered 
1 – Adequately 
covered 
0 – Poorly/not 
covered 
 
Score out of 36 =  
 
% =  
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Appendix 1.5: Data extraction tool 
 
 
Study authors: 
Study characteristics 
Study:  
Type of study:  
When conducted:  
Country:  
Setting:  
Study aims 
Primary aims:  
 
Secondary aims: 
 
 
 
Participant characteristics 
Parent participants/child participants/both 
Child participants 
Inclusion criteria:  
 
Sample size:  
 
Age range:  
 
Mean age:  
 
Gender: 
 
Disease severity: 
 
Length of diagnosis/age of diagnosis:  
 
Other: 
 
 
Parent participants 
Inclusion criteria: 
 
Sample size:  
 
Age range:  
 
Mean age:  
 
Gender: 
 
Other: 
96 
 
 
Child measure 
 
 
Family measure 
 
 
 
Statistical analysis 
  
 
 
 
Study results 
 
 
 
 
 
Notes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
97 
 
 
Appendices: Chapter 2 
Appendix 2.10: Change in design and difficulties with recruitment 
 
Change in planned design 
In the original proposal (see appendix 2.10, p. 139), the planned project had been to 
recruit family dyads (an adolescent and a parent/caregiver from each participating 
family) and for accounts to be analysed using Interpretative Phenomenological 
Analysis (IPA). Due to low uptake by families (see below), a decision was made to 
make an amendment to recruit health-professionals from the CF services involved in 
recruitment. IPA relies on gaining rich accounts of small, homogenous groups (Smith, 
Flowers & Larkin, 2009). Multi-perspective IPA studies are few in number but growing, 
for example, Rostill-Brookes et al. (2011) interviewed foster children, foster carers and 
social workers on their experiences of foster placement breakdown, providing three 
shared themes. However, the limited word count of a professional doctoral thesis 
precluded a more detailed presentation of the analysis, and so data was re-analysed 
using thematic analysis, which is a more versatile approach with less focus on rich 
accounts.  
Difficulties with recruitment 
Recruitment began in January 2018. CF clinical nurse specialists (CNS) issued 
research packs to all eligible families in NHS Highland and NHS Greater Glasgow & 
Clyde (n = 23). These were most frequently provided to potential participants at clinic 
appointments, with some being posted to families. There was a slow response from 
families, with the initial few respondents opting-out of further contact from the 
researcher. Although the researcher had planned to contact any families who had not 
opted-out within six weeks of receiving the research pack, it was decided that the CNS 
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would make further contact. This was deemed appropriate due to the longstanding 
relationship that the CNS have with the families. All families were approached by 
nurses on at least one further occasion to gauge their interest in the research. By May 
2018, all families had either participated or opted-out.  
Amendment 
As the group of potential participants had been exhausted an amendment was 
submitted in May 2018 to include the views of health-professionals within the research. 
Due to the slow uptake rate for families, it was thought that approaching another 
health-board would present the same issues.  
Reflections on recruitment  
On reflection, it may have been helpful to start the recruitment process earlier. This 
may have identified recruitment difficulties at an earlier stage and therefore allowed 
other plans to be put in place.  
From discussions with the CF CNS prior to recruitment, it was thought that the 
minimum numbers would be achieved and so the uptake rate was unexpectedly low. 
This was discussed with the CF CNS who felt that the timing of the research had 
been problematic as it coincided with exam periods in winter and spring 2018. One 
CNS described that adolescents had a general lack of interest in research, and that it 
had been difficult to recruit to a patient wellbeing survey ongoing on at the same 
time. Those in good health were thought to be especially focused on their exams, 
while those with poorer health tended to have difficulties attending appointments. 
Another CNS was surprised by the low uptake rate, and suggested that this may 
have been due to the sensitive nature of the research, or that there were fewer 
perceived benefits from taking part compared with other research, i.e. drug trials. 
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Appendix 2.2: Invitation letter for potential participants (V3, 27/10/17) 
 
 
 
 
 
 
Experiences of family relationships and managing cystic fibrosis in 
adolescence 
Dear <name> 
 
I am writing to let you know about some research that is being carried out by 
a final year Trainee Clinical Psychologist, Frieda Whelan. Frieda is completing the 
research as part of her doctoral degree at the University of Glasgow. 
 
Frieda is interested in the experiences of young people (aged 13-16) and their 
parents/caregivers as they grow older with cystic fibrosis. Please find enclosed 
participant information sheets (one for teenagers and one for caregivers) which 
describes the study and what will happen should you decide to take part. Please 
take your time to read through this and feel free to discuss with friends and family, or 
to get in touch with the research team. There are contact details for the team at the 
end of the participant information sheet. 
 
If you decide you would like to take part, please return the enclosed opt-in form to 
Frieda in the envelope provided. She will then contact you to discuss it in more 
detail.  
 
Please note that I am independent of the research team. If you decide not to take 
part it will have no impact on the service that you receive from the Cystic Fibrosis 
team.  
 
Thank you for taking the time to read this letter and to consider the research project. 
 
Yours sincerely, 
 
[CF nurse] 
Cystic Fibrosis Service 
 
Enclosed:  
Participant information sheet for teenagers 
Participant information sheet for caregivers 
Opt-in form 
Envelope to return opt-in form 
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Appendix 2.3: Participant information sheet for caregivers (V3, 20/10/17) 
 
 
 
 
 
Experiences of family relationships and managing cystic fibrosis in 
adolescence 
     Researcher: Frieda Whelan 
 
Participant information sheet for parents/caregivers 
This information sheet describes a study which is being carried out about teenagers 
and their experiences of growing up with cystic fibrosis (CF) and their relationships 
with family members. We are also interested in the views of the parents/caregivers.  
We would like to invite you to take part in the study, but first we would like to let you 
know about why the study is being done and what it would involve if you took part. 
Please read the information sheet carefully and you may wish to discuss it with 
someone else. If you have any questions please contact the researcher, Frieda 
Whelan, whose details are at the end. Thank you for reading this and for considering 
taking part in this study.  
1. Why is the study being done? 
The study aims to find out about the experiences of teenagers with CF. The aim is 
find out how teenagers find growing up with CF and about how their relationships 
with family affects this and vice versa. We are also interested in the views of the 
parent/caregiver. We know that growing up can be a difficult time, particularly with a 
health condition. Therefore, we are interested in how people might use family 
support at this time.  
2. Why have I been invited to take part? 
You are being asked to take part because you are the parent or caregiver of a 
teenager with CF being seen by the CF team in either NHS Highland or NHS 
Greater Glasgow & Clyde. The study hopes to recruit up to 10 people. 
 
3. Do we have to take part? 
No, it is up to you. If you decide to take part we will ask you to keep the information 
sheet and to sign a consent form. If you take part, you can stop taking part at any 
time. You will not need to give a reason and it will not affect the medical care of the 
teenager taking part. It will also not affect his/her medical care should you not wish to 
take part.  
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If you would like to take part, your teenager can decide whether they would like to 
take part also. However, if you would like to take part but the teenager does not, we 
will check with him/her that they agree to your participation. 
4. What happens if we/I decide to take part? 
If you decide to take part you will be asked to take part in one interview with the 
researcher (Frieda Whelan, who is a Trainee Clinical Psychologist). You will be 
interviewed alone, even if your family member also takes part. The interview will last 
up to an hour and will take place at a local hospital. The interview will be audio 
recorded and typed up and any details which could identify you will be removed. The 
interview will ask questions about having a child with CF. It will also ask about family 
relationships and how these might have changed as the teenager has gotten older.    
5. Will the study help me/us? 
There are no direct benefits to taking part. However, it could help the CF teams to 
understand more about how best to offer support to young people and their families.  
6. Are there any disadvantages about taking part? 
You might talk about experiences that cause you to feel some distress. You can stop 
the interview at any time and you can have a break whenever you wish. The 
researcher will check how you are feeling during the interview. You can stop the 
interview at any time and this will have no impact on your teenager’s medical care.  
Unfortunately we are not able to provide you with any expenses for travelling to the 
interview. 
7. Will my information be kept safe? 
Yes, all information will be kept safe and secure. Once the audio recording of the 
interview is typed up it will be destroyed. Any information which could identify you 
(for example, names or place names) will be removed as it is typed up. The typed-up 
interview will be given a study number so that your name is not on it. Some quotes 
might be used from your interview. If quotes are used, a pseudonym will be used and 
not yours.  
All information will be kept confidential. However, there may be times when 
information needs to be discussed with other professionals, for example, if the 
researcher is concerned about any risks to yourself or others. Frieda will try to 
discuss this with you if it is necessary.  
8. What will happen to the results of the study? 
Once the research is finished, the researcher (Frieda Whelan) will write up the 
project and submit it to the University of Glasgow as part of the Doctorate of Clinical 
Psychology degree. A report might also be submitted for publication in a journal.   
9. Further information and contact details 
If you have any questions or would like more information please contact one of the 
research team below: 
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Name Role Contact details 
Frieda Whelan Trainee Clinical 
Psychologist, Chief 
Investigator 
Phoenix Centre, 
Raigmore Hospital, 
Old Perth Road, 
Inverness 
IV2 3UJ 
01463 705597 
f.Whelan@research.gla.ac.uk  
Dr Alison 
Jackson 
Academic Supervisor  Institute of Health and Wellbeing, 
University of Glasgow, 
1st floor, Administration Building, 
Gartnavel Royal Hospital, 
1055 Great Western Road, 
Glasgow     
G12 0XH 
0141 211 3917 
 
10. Complaints 
 
If you have a complaint about any aspect of the research, please contact your 
health board below: 
 
 
 
 
 
 
 
 
 
NHS Highland The Feedback Team, NHS Highland, PO Box 5713, 
Inverness IV1 9AQ 
nhshighland.feedback@nhs.net  
01463 705997 
NHS Greater Glasgow & 
Clyde 
Complaints Department, West Glasgow Ambulatory 
Care Hospital, Dalnair Street, Glasgow G3 8SJ 
complaints@ggc.scot.nhs.uk 
0141 201 4500 
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Appendix 2.4: Participant information sheet for teenagers (V1, 20/10/17) 
 
 
 
 
 
Experiences of family relationships and managing cystic fibrosis in 
adolescence 
     Researcher: Frieda Whelan 
 
Participant information sheet for teenagers 
This information sheet describes a study which is being carried out about teenagers 
and their experiences of growing up with cystic fibrosis (CF) and their relationships 
with family members. We are also interested in the views of parents/caregivers.  
We would like to invite you to take part in the study, but first we would like to let you 
know about why the study is being done and what it would involve if you took part.  
Please read this information sheet carefully and you might want to talk about it with 
someone you know. If you have any questions please contact the researcher, Frieda 
Whelan, using the contact details at the end. 
Thank you for reading this and for thinking about taking part in the study.  
1. Why is the study being done? 
The study aims to find out about the experiences of teenagers with CF. We hope to 
find out about how teenagers find growing up with CF and about how their 
relationships with family affects this and vice versa. We are also interested in the 
views of your family, so we may ask your parent or caregiver to take part too. We 
know that growing up can be a difficult time, particularly with a health condition. 
Therefore, we are interested in how people might use family support at this time.  
2. Why have I been invited to take part? 
You are being asked to take part because you are aged 13-18, have CF and see the 
CF service in either NHS Highland or NHS Greater Glasgow & Clyde. 
We hope that up to ten people will take part in the study. 
3. Do I have to take part? 
No, it is up to you. If you decide to take part, we will ask you to keep the information 
sheet and to sign a consent form. If you take part, you can stop taking part at any 
time. You will not need to give a reason and it will not affect your medical care. Also, 
it will not affect your medical care if you choose not to take part. 
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We might also ask your parent/caregiver to take part. If they would like to take part 
but you do not want to, we will check with you that you are happy for your family 
member to take part. 
4. What happens if we/I decide to take part? 
If you decide to take part you will be asked to take part in one interview with Frieda, 
who is a Trainee Clinical Psychologist. You will be interviewed alone, even if your 
family member takes part too. The interview will last up to an hour and will take place 
at a local hospital. The interview will be audio recorded and typed up and any details 
which could identify you will be removed, for example your name. The interview will 
ask questions about growing up with CF. It will also ask about family relationships 
and how these might have changed with getting older.   
5. Will the study help me/us? 
There are no direct benefits to taking part. However, it could help the CF teams to 
understand more about how best to offer support to young people and their families.  
6. Are there any disadvantages about taking part? 
You might talk about experiences that make you feel upset. You can stop the 
interview at any time and you can have a break whenever you wish. The researcher 
will often check that you are feeling okay to continue. It might also be helpful for your 
parent/caregiver to wait in the waiting room while you take part. 
Unfortunately we are not able to provide you with any expenses for travelling to the 
interview.  
7. Will my information be kept safe? 
Yes, all information will be kept safe and secure. The audio recording of the interview 
will be deleted after it is typed up. Any information which could identify you (for 
example, names or place names) will be removed while it is typed up. The typed-up 
interview will be given a study number so that your name is not on it. Some quotes 
might be used from your interview. If quotes are used, a pretend name will be used 
and not yours.  
Frieda will keep your information confidential and private. If something you say 
during the interview makes Frieda worried about you or someone else, this may 
need to be passed on to someone else who cares for you, such as your doctor. If 
this happens, Frieda will try to talk to you about it first before telling anyone else. 
If you agree, Frieda will also write to your GP to let them know you are taking part. 
8. What will happen to the results of the study? 
Once the research is finished, Frieda will write up the project and submit it to the 
University of Glasgow as part of the Doctorate of Clinical Psychology degree. A 
report might also be submitted to a journal.   
9. Further information and contact details 
If you have any questions or would like more information, please contact one of the 
research team below: 
 
106 
 
 
Name Role Contact details 
Frieda Whelan Trainee Clinical 
Psychologist, Chief 
Investigator 
Phoenix Centre, 
Raigmore Hospital, 
Old Perth Road, 
Inverness 
IV2 3UJ 
01463 705597 
f.Whelan@research.gla.ac.uk  
Dr Alison 
Jackson 
Academic Supervisor  Institute of Health and Wellbeing, 
University of Glasgow, 
1st floor, Administration Building, 
Gartnavel Royal Hospital, 
1055 Great Western Road, 
Glasgow     
G12 0XH 
0141 211 3917 
 
10.  Complaints 
If you have a complaint about the research, please contact your health board 
below: 
 
 
 
 
 
 
 
 
NHS Highland The Feedback Team, NHS Highland, PO Box 5713, 
Inverness IV1 9AQ 
nhshighland.feedback@nhs.net  
01463 705997 
NHS Greater Glasgow & 
Clyde 
Complaints Department, West Glasgow Ambulatory 
Care Hospital, Dalnair Street, Glasgow G3 8SJ 
complaints@ggc.scot.nhs.uk 
0141 201 4500 
107 
 
 
Appendix 2.5: Participant information sheet for health-professionals (V2, 
12/6/18) 
 
 
 
 
 
Experiences of family relationships and managing cystic fibrosis in 
adolescence 
     Researcher: Frieda Whelan 
 
Participant information sheet for health professionals 
This information sheet describes a study which is being carried out about teenagers 
and their experiences of growing up with cystic fibrosis (CF) and their relationships 
with family members. We are also interested in the views of the parents/caregivers 
and health professionals.  
We would like to invite you to take part in the study, but first we would like to let you 
know about why the study is being done and what it would involve if you took part. 
Please read the information sheet carefully. If you have any questions please contact 
the researcher, Frieda Whelan, whose details are at the end. Thank you for reading 
this and for considering taking part in this study.  
1. Why is the study being done? 
The study aims to find out about the experiences of teenagers with CF. The aim is 
find out how teenagers find growing up with CF and about how their relationships 
with family affects this and vice versa. We are also interested in the views of the 
parent/caregiver and health professionals. We know that growing up can be a 
difficult time, particularly with a health condition. Therefore, we are interested in how 
people might use family support at this time.  
2. Why have I been invited to take part? 
You are being asked to take part because you are a health professional 
working within a CF service in either NHS Highland or NHS Greater Glasgow 
& Clyde. The study hopes to recruit up to 10 people in total. 
 
3. Do I have to take part? 
No, it is up to you. If you decide to take part we will ask you to keep the information 
sheet and to sign a consent form. If you take part, you can stop taking part at any 
time, with giving a reason.  
108 
 
 
4. What happens if we/I decide to take part? 
If you decide to take part you will be asked to take part in one interview with the 
researcher (Frieda Whelan, who is a Trainee Clinical Psychologist). The interview 
will last up to an hour and will take place at the hospital or by phone. The interview 
will be audio recorded and typed up and any details which could identify you or 
others will be removed. The interview will ask questions about your experience of 
working with teenagers with CF and their families.  
5. Will the study help me? 
There are no direct benefits to taking part. However, the research could help teams 
working with young people with CF and their families to understand more about how 
best to offer support during adolescence.   
6. Are there any disadvantages about taking part? 
It is not expected that the interview will cause any distress or difficulties. However, 
you are free to withdraw your participation at any time without giving a reason.  
7. Will my information be kept safe? 
Yes, all information will be kept safe and secure, and only the research team will 
have access to it. Once the audio recording of the interview is typed up it will be 
destroyed. Any information which could identify you (for example, names or place 
names) or others will be removed as it is typed up. The typed-up interview will be 
given a study number so that your name is not on it. Some quotes might be used 
from your interview. If quotes are used, a pseudonym will be used and not yours.  
8. What will happen to the results of the study? 
Once the research is finished, the researcher (Frieda Whelan) will write up the 
project and submit it to the University of Glasgow as part of the Doctorate of Clinical 
Psychology degree. A report might also be submitted for publication in a journal.   
9. Further information and contact details 
If you have any questions or would like more information please contact one of the 
research team below: 
 
Name Role Contact details 
Frieda Whelan Trainee Clinical 
Psychologist, Chief 
Investigator 
Phoenix Centre, 
Raigmore Hospital, 
Old Perth Road, 
Inverness 
IV2 3UJ 
01463 705597 
f.Whelan@research.gla.ac.uk  
Dr Alison 
Jackson 
Academic Supervisor  Institute of Health and Wellbeing, 
University of Glasgow, 
1st floor, Administration Building, 
Gartnavel Royal Hospital, 
1055 Great Western Road, 
Glasgow     
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G12 0XH 
0141 211 3917 
Professor 
Andrew Jahoda 
Independent research 
advisor 
Institute of Health and Wellbeing, 
University of Glasgow, 
1st floor, Administration Building, 
Gartnavel Royal Hospital, 
1055 Great Western Road, 
Glasgow     
G12 0XH 
0141 2110282 
 
10. Complaints 
 
If you have a complaint about any aspect of the research, please contact your 
healthboard below: 
 
11. NHS Highland GDPR information 
NHS Highland is the sponsor for this study based in the United Kingdom. We will be 
using information from you in order to undertake this study and will act as the data 
controller for this study. This means that we are responsible for looking after your 
information and using it properly. NHS Highland will keep identifiable information 
about you for seven years after the study has finished. 
Your rights to access, change or move your information are limited, as we need to 
manage your information in specific ways in order for the research to be reliable and 
accurate. If you withdraw from the study, we will keep the information about you that 
we have already obtained. To safeguard your rights, we will use the minimum 
personally-identifiable information possible.  
You can find out more about how we use your information at 
http://www.nhshighland.scot.nhs.uk/Pages/YourRights.aspx or by contacting Donald 
Peterkin (Interim Data Protection Officer, NHS Highland) on 01463 704000 
 
NHS Highland The Feedback Team, NHS Highland, PO Box 5713, 
Inverness IV1 9AQ 
nhshighland.feedback@nhs.net  
01463 705997  
NHS Greater Glasgow & 
Clyde 
Complaints Department, West Glasgow Ambulatory 
Care Hospital, Dalnair Street, Glasgow G3 8SJ 
complaints@ggc.scot.nhs.uk 
0141 201 4500 
Argyll and Bute Health 
and Social Care 
Partnership 
The Feedback Team, Argyll and Bute Health and Social 
Care Partnership, Main Building, Victoria Integrated 
Care Centre, 93 East King Street, Helensburgh G84 
7BU 
Argyllandbutehscp.feedback@nhs.net  
01436 635155 
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Appendix 2.6: Example consent/assent forms  
Separate consent forms were for developed for: teenagers under 16, teenagers 16+, 
caregivers and health-professionals. Assent forms were developed for teenagers to 
consent to caregiver participation if the teenager was not participating, and for 
caregivers to agree to the participation of a teenager under 16. Examples of a consent 
and an assent form are given below. 
 
 
 
 
 
Experiences of family relationships and managing cystic fibrosis in 
adolescence 
     Researcher: Frieda Whelan 
Consent form (for under 16s) 
 
Thank you for your interest in the study. This form is to make sure you are happy to 
take part in the study and know exactly what it involves.  
Please read the following sentences carefully. If you agree with them please sign 
your initials in the boxes. Please sign and put the date at the bottom of this sheet if 
you agree to taking part in the study. 
 
          Please initial  
1. I have had a chance to ask questions about the study. 
 
2. I am happy with the answers I have been given to my questions.  
 
 
3. I have been told enough information about the study. 
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4. I agree to the interview being audio recorded. I also agree to the    
researcher typing out the interview, word by word, and removing any   
information about people and places so that no one can tell the   
interview is about me.  
 
 
5. I agree to the research team looking at my interview, and some parts  
of the interview being used in a report so long as I cannot be identified                          
in it.  
 
6. I understand that the information I give will be kept safely. Only the                                                       
research team will be able to see it. 
 
7. I understand that it is my choice to take part in the study. I can stop                     
taking part at any time. I do not have to give a reason and it will not  
affect my medical care.  
 
8. I agree that the research team can tell my GP I am taking part.  
 
 
9. I agree to take part in the above study. 
 
__________________________  Date ______________ Signature _____________ 
Participant 
 
__________________________Date _______________ Signature ____________ 
Researcher 
1 copy for participant, 1 copy for researcher 
 
 
Would you like a summary of the results of the research once the project is complete 
(approximately August 2018)? Please tick. 
               Yes, by email. My email address is ______________________________ 
 
                Yes, by post. My home address is ________________________________ 
            
     No thank you 
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Experiences of family relationships and managing cystic fibrosis in 
adolescence 
     Researcher: Frieda Whelan 
Assent form for parent/caregiver (for under 16s) 
This form is to make sure you are happy for your child to take part in the study and 
know exactly what it involves.  
Please read the following sentences carefully. If you agree with them please sign 
your initials in the boxes. Please sign and put the date at the bottom of this sheet if 
you agree to your child taking part in the study. 
          Please initial  
1. I have had a chance to ask questions about the study that my child will                                                   
take part in and I am happy with the answers I have been given. 
 
2. I agree to the interview being audio recorded. I also agree to the    
researcher typing out the interview, word by word, and anonymising the                                                 
information so my child cannot be identified. I agree that anonymous                                                     
quotes can be used in reports/publications. 
 
3. I understand that my child’s participation is voluntary and they can stop                     
taking part at any time. They do not have to give a reason and it will not 
           affect their medical care.  
 
4. I agree to my child’s GP being informed of their participation in the study.  
 
 
5. I agree to my child taking part in the above study. 
 
Child’s name ______________________ 
 
__________________________  Date ______________ Signature _____________ 
Parent/caregiver 
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__________________________Date _______________ Signature ____________ 
Researcher 
1 copy for parent/caregiver, 1 copy for researcher 
 
 
Would you like a summary of the results of the research once the project is complete 
(approximately August 2018)? Please tick. 
               Yes, by email. My email address is ______________________________ 
 
                Yes, by post. My home address is ________________________________ 
            
     No thank you 
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Appendix 2.7: Interview guides 
Interview schedule for teenagers (V1, 23/8/17) 
Thank you for meeting with me today, my name is Frieda Whelan and I am a trainee 
Clinical Psychologist working for NHS Highland, undertaking a research project as 
part of my training. I am working alongside the CF team for my research project and 
am supervised by a psychologist within the team. 
As you will be aware, the study is aimed at finding out more about the experiences of 
young people with cystic fibrosis. In particular it aims to explore relationships as a 
young person gets older and how this might affect managing CF. I will be recording 
today’s interview so I can refer back to the information. Everything you say will be 
confidential and the information recorded will be stored securely. I may pass on 
information if there is anything which would make me concerned about the safety of 
yourself or someone else or if I feel you may benefit from more support from the 
team. I may pass this information on to the CF team, however, I would try to discuss 
this with you first. The interviews are anonymised, including any information which is 
used in a report of the study. You can withdraw from the interview at any time 
without having to give a reason, and this will not affect your clinical care. The 
interview will take up to an hour – please tell me if you would like a break at any 
point during the interview.  
Young person’s life with CF 
• Can you tell me about what it is like to live with CF, at the moment? 
o Prompt: how does CF affect your day to day to life at the moment?  
• What is going well/more difficult? 
 
Exploring relationships at home 
• Can you tell me about the people around you? (use a genogram/mapping 
exercise to plot who helps and in what way) 
o Prompt: who is in your family? Who else is around for you?  
• Can you describe what closeness looks like in your family? 
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• Can you describe what gets in the way of closeness at home/what does 
distance look like? 
• In your mind, what do you think your (main caregivers) think of CF? 
• In what way, if any, does this influence closeness/distance?  
Experiences of CF with transition into adolescence 
• Has there been any change in how your CF affects day to day life as you 
have gotten older? 
o Prompt: how are things different now that you are in high school 
compared with primary school? 
• Can you describe what these changes feel like for you? 
• Has there been change in how confident you feel in managing your condition 
since you’ve gotten older? Can you tell me more about it? 
o Prompt: what does that feel like? 
• How do you feel about the level of support you have to manage the condition? 
o Prompt: would you prefer more or less? Why?  
o Prompt: would you want the support to be different? In what way? 
Exploring relationships and CF management 
• As you’ve gotten older, how have your conversations with your family about 
CF changed?  
o Prompt: if no changes, why do you think this is? If there have been 
changes, how do you feel about this? 
• Since becoming older, have you found that your relationships have changed? 
• In what way have they changed?   
• What has worked well in the relationship between you and (caregiver) in 
managing your CF? 
• Is there anything about your relationship which makes it more difficult to 
manage your CF? 
Effect of rurality/urban 
• Have you experienced any challenges in attending appointments? 
• Does living in a more rural area influence life with CF? Can you tell me more? 
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Interview schedule for caregivers (V1, 23/8/17) 
 
Thank you for meeting with me today, my name is Frieda Whelan and I am a trainee 
Clinical Psychologist working for NHS Highland, undertaking a research project as 
part of my training. I am working alongside the CF team for my research project and 
am supervised by a psychologist within the team. 
As you will be aware, the study is aimed at finding out more about the experiences of 
caregivers of young people with cystic fibrosis. In particular it aims to explore 
relationships as a young person gets older and how this might affect managing their 
condition. I will be recording today’s interview so I can refer back to the information. 
Everything you say will be confidential and the information recorded will be stored 
securely. I may pass on information if there is anything which would make me 
concerned about the safety of yourself or someone else or if I feel you may benefit 
from more support from the team. I may pass this information on to the CF team, 
however, I would try to discuss this with you first. The interviews are anonymised, 
including any information which is used in a report of the study. You can withdraw 
from the interview at any time without having to give a reason, and this will not affect 
your clinical care. The interview will take up to an hour - please tell me if you would 
like a break at any point during the interview.  
Demographic information 
• What is your relationship to [young person with CF]? 
General opening question 
• Can you tell me about what it is like to be the [parent etc.] of (adolescent’s 
name)? 
• Can you describe what it is like to parent a young person with CF, at the 
moment?  
o Prompt: how does them having CF affect day to day to life at the 
moment?  
o Prompt: what is going well/more difficult? 
o Prompt: how do you feel about the support you have to manage (x’s) 
condition? 
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Exploring relationships at home 
• Can you tell me about who is around you and (x) at home?  
o Prompt: who is in your family? Who else is around you and (x)? 
• Can you describe what closeness looks like in your family? 
• Can you describe what gets in the way of closeness at home/what does 
distance look like? 
• In your mind, what do you think (x’s name) thinks of CF? 
• In what way, if any, does this influence closeness/distance?  
Experiences of CF with transition into adolescence 
• Has there been any change in how CF affects (x’s) life day to day as they’ve 
gotten older? 
o Prompt: how are things different now they are in high school compared 
with primary school? 
• When did you notice things changing? 
• Have you noticed a change in how confident (x) is in managing their CF as 
she/he has gotten older? Can you tell me more about it? 
o Prompt: how do you feel about these changes? 
• How do you feel about the support (family and professional) (x) has received 
in doing this?  
o Prompt: would you prefer them to have more or less support? Why? 
o Would you want the support to be different? In what way? 
Exploring relationships and CF management 
• How have your conversations changed about CF as (x) has gotten older?  
o Prompt: if not, why do you think this is?  
o Prompt: how do you feel about the level of support/guidance you have 
received for these types of conversations?  
• What way, if any, has your relationship changed as (x) grows older? 
• In what way has it changed? 
• What has worked well in the relationship between you and (x) in managing 
their CF? 
• Is there anything about your relationship which makes it more difficult for you 
and (x) to manage CF?  
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Effect of rurality/urban 
• Have you experienced any challenges in attending appointments? 
• Does living in a more rural area influence life with a young person with CF? 
Can you tell me more?  
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Interview schedule for health-professionals (V1, 11/5/18) 
Thank you for meeting with me today, my name is Frieda Whelan and I am a trainee 
Clinical Psychologist working for NHS Highland, undertaking a research project as 
part of my training. As you will be aware I am working alongside the CF team for my 
research project and am supervised by a psychologist within the team. 
The study is aimed at finding out more about the experiences of young people with 
cystic fibrosis. In particular it aims to explore relationships as a young person gets 
older and how this might affect managing CF. I am also interested in this from the 
perspective of health professionals working closely with young people with CF and 
families. 
 I will be recording today’s interview so I can refer back to the information. Everything 
you say will be confidential and the information recorded will be stored securely. The 
interviews are anonymised, including any information which is used in a report of the 
study. You can withdraw from the interview at any time without having to give a 
reason. The interview will take up to an hour – please tell me if you would like a 
break at any point during the interview.  
 
General questions about working with families 
• Can you tell me about what it’s like to work with young people with CF and 
their families? 
• What are the families like that you work with? 
 
 
Questions about working with families during adolescence  
• Can you tell me about what it’s like to work with the families of adolescents 
with CF? 
o Prompt: what works well (during adolescence in particular)? 
o Prompt: are there any challenges (during adolescence in particular)? 
What are they? 
o Prompt: how does adolescence differ from other ages/stages?  
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• Have you noticed changes in changes in family relationships over 
adolescence? Can you describe these? 
 
Questions about the interaction of CF with family relationships 
• Do you think CF affects family relationships? If yes, in what way? If no, why? 
 
• Do you think family relationships can affect how a young person manages 
CF? 
 
Questions about family support 
• Can you tell me about your views on the role of family for teenagers with CF? 
o Prompt: how do families help teenagers with CF? 
o Prompt: how do families hinder teenagers with CF? 
• What do you think works well in terms of family support? 
• What do you think works less well in terms of family support? 
• What kind of support would be offered/suggested to families who are 
experiencing difficulties?  
• Question about recruitment to project 
 
• Why do you think it’s been difficult to recruit families for a research project 
looking at experiences of CF and family relationships in adolescence? 
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Appendix 2.8: Approval from Research Ethics Committee and Research and 
Development  
 
  
  
Lothian NHS Board  South East Scotland Research  
Ethics Committee 01  
  
Waverley Gate  
2-4 Waterloo Place  
 Edinburgh  
                                            EH1 3EG  
                        Telephone 0131 536 9000  
  
www.nhslothian.scot.nhs.uk  
  
  Date  06 December 2017  
10 November 2017    
(re-issued 06 Dec 2017 with corrections)        
  Enquiries to:   Sandra Wyllie  
Mrs Frieda Whelan  Extension:      35473    
Trainee Clinical Psychologist  Direct Line:    0131 465 5473  
NHS Highland  
New Craigs Hospital  
6-16 Leachkin Road  
Inverness  
IV3 8NP  
  
  
  
Dear Mrs Whelan   
  
Email:   Sandra.Wyllie@nhslothian.scot.nhs.uk  
  
  
Study title:  Experiences of family relationships and managing 
cystic fibrosis in adolescence using Interpretative  
Phenomenological Analysis  
REC reference:  17/SS/0138  
IRAS project ID:  228143  
  
Thank you for your letter of 03 November 2017, responding to the Committee’s 
request for further information and for submitting revised documentation.  
  
The further information has been considered on behalf of the Committee by the 
Chair.   
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We plan to publish your research summary wording for the above study on the HRA 
website, together with your contact details. Publication will be no earlier than three 
months from the date of this opinion letter.  Should you wish to provide a substitute 
contact point, require further information, or wish to make a request to postpone 
publication, please contact hra.studyregistration@nhs.net outlining the reasons for 
your request.  
  
Confirmation of ethical opinion  
  
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the application form, protocol and 
supporting documentation as revised, subject to the conditions specified below.  
  
  
Conditions of the favourable opinion  
  
The REC favourable opinion is subject to the following conditions being met prior to 
the start of the study.  
  
Management permission must be obtained from each host organisation prior to the 
start of the study at the site concerned.  
  
Management permission should be sought from all NHS organisations involved in 
the study in accordance with NHS research governance arrangements. Each NHS 
organisation must confirm through the signing of agreements and/or other 
documents that it has given permission for the research to proceed (except where 
explicitly specified otherwise).   
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk.    
  
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites ("participant identification centre"), guidance 
should be sought from the R&D office on the information it requires to give 
permission for this activity.  
  
For non-NHS sites, site management permission should be obtained in accordance 
with the procedures of the relevant host organisation.   
  
Sponsors are not required to notify the Committee of management permissions from 
host organisations  
  
Registration of Clinical Trials  
  
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database within 6 weeks of recruitment of the 
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first participant (for medical device studies, within the timeline determined by the 
current registration and publication trees).    
  
There is no requirement to separately notify the REC but you should do so at the 
earliest opportunity e.g. when submitting an amendment.  We will audit the 
registration details as part of the annual progress reporting process.  
  
To ensure transparency in research, we strongly recommend that all research is 
registered but for non-clinical trials this is not currently mandatory.  
  
If a sponsor wishes to request a deferral for study registration within the required 
timeframe, they should contact hra.studyregistration@nhs.net. The expectation is 
that all clinical trials will be registered, however, in exceptional circumstances non 
registration may be permissible with prior agreement from the HRA. Guidance on 
where to register is provided on the HRA website.    
  
It is the responsibility of the sponsor to ensure that all the conditions are 
complied with before the start of the study or its initiation at a particular site 
(as applicable).  
  
Ethical review of research sites  
  
NHS sites  
  
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of the study (see "Conditions of the favourable opinion" below).  
   
  
Approved documents  
  
The final list of documents reviewed and approved by the Committee is as follows:  
  
Document    Version    Date    
Copies of advertisement materials for research 
participants [Poster advertising study]   
2   23 August 2017   
Covering letter on headed paper [Cover letter - changes 
]   
1   03 November 
2017   
GP/consultant information sheets or letters [GP letter for 
adolescent participants]   
1   20 October 2017   
Interview schedules or topic guides for participants 
[Interview schedule for caregiver participants]   
3   23 August 2017   
Interview schedules or topic guides for participants 
[Interview schedule for adolescent participants]   
3   23 August 2017   
Letters of invitation to participant [Letter of invitation - 
Glasgow]   
3   27 October 2017   
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Letters of invitation to participant [Letter of invitation - 
Highland]   
2   27 October  
2017   
Other [Opt in form]   3   03 November 
2017   
Participant consent form [Consent form for participants 
aged 16+]   
3   03 November 
2017   
Participant consent form [Consent form for participants 
aged under 16]   
3   20 October 2017   
Participant consent form [Assent form for 
parents/caregivers if participant under 16]   
3   20 October 2017   
Participant consent form [Teen assent form is parent but 
not teen participating]   
1   20 October  
2017   
Participant consent form [Consent form for caregivers]   1   03 November 
2017   
Participant information sheet (PIS) [Participant 
information sheet for caregivers]   
3   20 October 2017   
Participant information sheet (PIS) [Participant 
information sheet for adolescents]   
1   20 October 2017   
REC Application Form [REC_Form_29082017]      29 August 2017   
Research protocol or project proposal [Research 
protocol]   
2   20 October 2017   
Summary CV for Chief Investigator (CI) [CV for chief 
investigator]   
1   23 August 2017   
Summary CV for supervisor (student research) [CV for 
academic supervisor]   
1   23 August 2017   
  
Statement of compliance  
  
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.  
  
After ethical review  
  
Reporting requirements  
  
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including:  
  
• Notifying substantial amendments  
• Adding new sites and investigators  
• Notification of serious breaches of the protocol  
• Progress and safety reports  
• Notifying the end of the study  
125 
 
 
  
The HRA website also provides guidance on these topics, which is updated in the 
light of changes in reporting requirements or procedures.  
  
  
User Feedback  
  
The Health Research Authority is continually striving to provide a high quality service 
to all applicants and sponsors. You are invited to give your view of the service you 
have received and the application procedure. If you wish to make your views known 
please use the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/     
  
HRA Training  
  
We are pleased to welcome researchers and R&D staff at our training days – see 
details at http://www.hra.nhs.uk/hra-training/    
  
  
17/SS/0138                          Please quote this number on all correspondence  
  
With the Committee’s best wishes for the success of this project.  
  
Yours sincerely  
  
  
  
Mrs Christine Beadle Chair  
  
Email:sandra.wyllie@nhslothian.scot.nhs.uk  
  
Enclosures:    “After ethical review – guidance for  
    researchers”   
  
Copy to:  Ms Frances Hines, NHS Highland  
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Administrator: Sophie Bagnall  R&D 
Management 
Office  
Telephone Number: 0141 232 1826  West Glasgow 
ACH  
E-Mail: sophie.bagnall@ggc.scot.nhs.uk  Dalnair Street  
Website: www.nhsggc.org.uk/r&d  
  
Glasgow G3 
8SW  
    
        
6 December 2017  
  
Dr Ruth Hind  
Clinical Psychology  
NHS Greater Glasgow & Clyde  
Department of Paediatric Clinical Psychology  
Royal Hospital for Children  
Glasgow  
G51 4TF  
  
NHS GG&C Board Approval  
Dear Dr Hind,  
  
 
Study Title:   Experiences of family relationships and managing 
cystic fibrosis in adolescence using Interpretative 
Phenomenological Analysis  
Principal 
Investigator:    
Dr Ruth Hind  
GG&C HB site  Royal Hospital for Children  
Sponsor  NHS Highlands  
R&D reference:  GN17RM427  
REC reference:  17/SS/0138  
Protocol no:  v2 20.10.17  
  
I am pleased to confirm that Greater Glasgow & Clyde Health Board is now able to 
grant Approval for the above study.    
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Conditions of Approval  
1. For Clinical Trials as defined by the Medicines for Human Use Clinical 
Trial Regulations, 2004 a. During the life span of the study GGHB 
requires the following information relating to this site  
i. Notification of any potential 
serious breaches. ii. Notification 
of any regulatory inspections.  
  
It is your responsibility to ensure that all staff involved in the study at this site have 
the appropriate GCP training according to the GGHB GCP policy 
(www.nhsggc.org.uk/content/default.asp?page=s1411), evidence of such training to 
be filed in the site file  
2. For all studies the following information is required during their lifespan.  
a. Recruitment Numbers on a monthly basis 
b. Any change of staff named on the original SSI form 
c. Any amendments – Substantial or Non Substantial 
d. Notification of Trial/study end including final recruitment figures 
e. Final Report & Copies of Publications/Abstracts 
 
Please add this approval to your study file as this letter may be subject to audit 
and monitoring.  
Your personal information will be held on a secure national 
web-based NHS database. I wish you every success with this 
research study  
Yours sincerely,  
  
Sophie Bagnall Senior Research Administrator  
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Appendix 2.9: Approval from Research Ethics Committee and Research and 
Development for amendment  
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Document: AM Approval letter 
27.02.17  
R&D Ref No: 1329  
REC Ref No: 17/SS/0138  
NRS Ref No: NRS17/228143  
EudraCT Ref No: NA MHRA  
Ref No: NA  
Today’s Date: 18/06/2018 
 
Frances Hines  
Research, Development & 
Innovation Manager  
NHS Highland  
Research, Development & 
Innovation Department  
Centre for Health Science  
Old Perth Road 
Inverness IV2 3JH  
Tel: 01463 255821  
E-mail: 
frances.hines@nhs.net  
 
 
 
 
Dr Stephanie Bannon 
Clinical Psychologist 
NHS Highland 
Phoenix Centre 
Old Perth Road 
Inverness IV2 3JH 
By email: s.bannon@nhs.net 
 
 
Dear Dr Bannon, 
 
LETTER OF APPROVAL OF YOUR RESEARCH PROJECT AMENDMENT 
 
PROJECT TITLE:   Experiences of family relationships and managing cystic 
fibrosis in adolescence using Interpretative 
Phenomenological Analysis 
REC: 17/SS/0138 
NHS Highland R&D Ref Number: 1329 
 
Amendment Type: 
 
Substantial (SA) √ 
Modified SA  
Non-substantial 
(NSA) 
 
Amendment No: 
 
AM 01 
Amendment Date: 11.05.18 
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Current Protocol 
Version No: 
 
V3 Dated 11.05.18 
We have been notified of the above amendment to your research project and have 
received the following documents:  
 
• Notification of Substantial Amendment form.  
• Amended documents corresponding with those approved in the REC 
amendment approval letter (South East Scotland Research Ethics Committee 
01) dated 13.06.18.  
 
The RD&I Division, NHS Highland, is happy to approve this amendment as it is within 
the scope of the original Management Approval Letter (05.12.17). 
 
Yours sincerely, 
 
 
 
 
 
Frances Hines 
NHS Highland Research, Development & Innovation Manager 
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Dear Dr Hind, 
  
R&D Ref: GN17RM427    Ethics Ref: 17/SS/0138 
Investigator: Dr Ruth Hind 
Project Title: Experiences of family relationships and managing cystic fibrosis in 
adolescence using Interpretative Phenomenological Analysis 
Protocol Number: v3 11.05.18 
Amendment: SA01 11/05/18 and NSA02 
Sponsor: NHS Highlands 
  
I am pleased to inform you that R&D have reviewed the above study's Amendments 
SA01 11/05/18 and NSA02 and can confirm that Management Approval is still valid 
for this study. 
  
I wish you every success with this research project. 
  
  
Reviewed 
Documents:                                                           
 Version   Dated 
Ethics approval   13/06/18 
Notice of substantial amendment   11/05/18 
Letter of invitation to participant (Clyde/Argyll) 1 11/05/18 
Letter of invitation to participant (Glasgow adult 
service) 1 11/05/18 
Staff interview schedule 1 11/05/18 
Consent form (staff participants) 1 11/05/18 
Information sheet (adolescents) 3 12/06/18 
Information sheet (caregivers) 5 12/06/18 
Information sheet (staff) 2 12/06/18 
Protocol 3 11/05/18 
Notice of minor amendment (clarification)   29/06/18 
  
Yours sincerely, 
  
  
Research and Development Department 
NHS Greater Glasgow and Clyde 
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Appendix 2.10: Research proposal 
Experiences of family relationships and managing cystic fibrosis in 
adolescence using Interpretative Phenomenological Analysis 
 
Abstract 
Background 
Early detection and improved treatments have meant that the life expectancy of those 
with cystic fibrosis (CF) has improved. However, those with CF and their caregivers 
can experience elevated levels of anxiety and depression. Accordingly, there is a need 
to provide for the psychological needs of people with CF and their families. Families 
may need support during significant life transitions such as from childhood into 
adolescence. However, there are few qualitative studies on how family relationships 
and support interacts with CF during adolescence; a time when increasing 
responsibility for treatment may be expected.  
 
Aims 
The aim of the study is to explore adolescent and caregiver experiences of the 
transition into adolescence with CF and how family factors interact with this. This will 
be explored using Interpretative Phenomenological Analysis (IPA). 
 
Methods 
Four to ten interviews will be carried out with adolescents with CF (aged 13-18) and 
caregivers, who will be purposively recruited from two CF services in NHS Highland 
and NHS Greater Glasgow & Clyde. Individuals will be interviewed on their 
experiences and the interviews analysed with IPA to generate common themes.  
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Applications 
The results could help services to understand more about how individuals experience 
CF into adolescence, and what factors in the family may help or hinder the 
management of the condition, allowing for assessment and intervention to be adapted. 
 
Introduction 
Cystic fibrosis (CF) is a life-limiting genetic condition, affecting 10, 583 people in the 
UK, including 970 in Scotland, during 2014 (Cystic Fibrosis Trust, 2015). Median life 
expectancy has increased by 10 years in recent times and is currently 47 in the UK 
(Cystic Fibrosis Trust, 2016). Early detection through newborn screening, along with 
improvements in medical treatments has contributed to this. Additionally, future 
treatments are being investigated which target the genes implicated in CF and may 
hold promise in further improving life expectancy (Antoniou & Elston, 2016). Thus, 
there is growing need to meet the longer-term psychological needs of those with CF 
and their families. 
 
The chronic and life-limiting nature of CF, along with the demands of managing the 
condition, can pose challenges to the family. Indeed, individuals with CF and their 
caregivers experience elevated levels of anxiety and depression, which in turn can 
affect treatment adherence and use of health services (Quittner et al., 2016). A 
systematic review of 43 qualitative studies exploring children and adolescents’ 
experiences of CF highlights the unique challenges they can face growing up with CF, 
along with resilience factors (Jamieson et al., 2014).  Themes included developing 
resilience, recognising restrictions, challenges of chronic treatment, effect of time 
limitations, emotional difficulties and thoughts around transplants.  Altogether, the 
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studies included at least 729 children, however, just 12 of them included only 
adolescents (per the World Health Organisation definition of adolescence as spanning 
ages 10 to 19, WHO, n.d.).   
 
Adolescence is a complex time, particularly with CF when children will gradually take 
on more responsibility for the management of their condition, whilst continuing to share 
responsibility with their parents (Drotar & Ievers, 1994). In early adolescence, 
individuals will transition from primary to secondary school, which will bring with it 
increased independence which may impact on the balance of responsibility for the 
management of their condition. Berge and Patterson (2004) review studies regarding 
family functioning and CF and highlight the complexity of the issue of how much 
responsibility to confer to the adolescent, and how this remains unresolved in the 
literature. Only six of the 54 studies were qualitative and none of the six studies 
considered a solely adolescent sample.  A qualitative approach could be particularly 
useful because it affords a deeper understanding of the complexity of family 
relationships.  
 
The nature of family relationships can be associated with treatment adherence and 
emotional distress. In one study, a more positive family environment was associated 
with increased self-reported adherence to lung treatments (DeLambo, Ievers-Landis, 
Drotar, and Quittner, 2004). Family relationships have also been related to emotional 
coping, for example, parent-reported attachment and communication have been 
shown to be related to self-reported internalising problems and emotional symptoms 
in young people with CF (Tluczek et al., 2014). Graetz, Shute and Sawyer (2000) 
explored behaviours that adolescents perceive as supportive and non-supportive. 
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They found that perceived non-supportive behaviours from family members was a 
strong predictor of psychological maladjustment, however, they only asked one 
question around non-supportive behaviours and did not consider the mechanisms by 
which this might happen. Support from family members is likely to be of increasing 
importance since it is recommended that individuals with CF are segregated as an 
infection control measure (Cystic Fibrosis Trust, 2004).  
 
Understanding the interplay of a chronic health condition with family relationships may 
be well-suited to a qualitative approach, for example Interpretative Phenomenological 
Analysis (IPA), which can help to explore how individuals make sense of significant 
life experiences through interpretation of rich and detailed data (Smith & Eatough, 
2007).  
 
Aims 
There is a paucity of qualitative research on the relationship between growing up with 
CF and family relationships in adolescence. The aims of the present study are to 
explore the experience of adolescents’ transition from late childhood to adolescence 
with a chronic health condition, and how family factors interact with this. Particularly, 
the research aims to ask whether there are changes in relationships, what works well 
in terms of family support, and what is problematic.  
 
Plan of investigation 
- Participants 
Participants aged 13-16 will be purposively recruited through the paediatric service at 
the Royal Hospital for Children, NHS Greater Glasgow and Clyde (NHS GG&C). As of 
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October 2016, 26 of individuals currently under review were aged 12-16. In NHS 
GG&C, adolescents independently attend transition clinics between the ages of 14 
and 16, and move into adult services at age 17.  
 
Participants aged 13-18 will be recruited through NHS Highland. Five of the fourteen 
families being seen by the CF service will be eligible to take part during the recruitment 
period. The CF nurse for NHS Highland, who will act as a gatekeeper for recruitment, 
knows the families well and believes that there would be interest in taking part in 
research.  There is no psychologist attached to the team but input from the paediatric 
health psychology service is available on a referral basis. In NHS Highland, the clinical 
team and hospital at which adolescents are seen remains unchanged into transition. 
The medical consultant changes, however, the CF nurse covers both paediatric and 
adult populations. At age 14 adolescents are introduced to the adult consultant and 
transition occurs between the ages of 16 and 18 (dependent on leaving school).  
 
Participants will be aged between 13 and 16/18. This will allow for a relatively 
homogenous population to be recruited. Adolescents of this age will have left primary 
school, meaning they have experienced a significant life event (i.e. transition to high 
school), which inevitably affects independence. This could also affect responsibility for 
health management. Caregivers of adolescents meeting the above criteria will also be 
recruited. To ensure the study is open to adolescents from different family 
backgrounds, the caregiver could be a mother, father or other relative who is a primary 
caregiver for the participant. Details of the relationship of the caregiver will be 
collected.  Obtaining more than one perspective will afford a richer understanding of 
family relationships during adolescence (Smith, Flowers & Larkin, 2009, p. 52).  
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Caregivers and adolescents of each family will both be invited to participate; however, 
it will not be necessary for both to participate. If a caregiver is willing to participate but 
not the adolescent, it will be ensured that the adolescent agrees to the caregiver’s 
participation and to sharing of information which pertains to them.  
 
- Inclusion and exclusion criteria 
Inclusion criteria: 
• CF diagnosis/are the primary caregiver of an adolescent with a CF diagnosis 
• Attendance at CF service at the Royal Hospital for Children, Glasgow or 
Raigmore Hospital, Inverness 
• Fluent in English 
• Aged 13-18/a caregiver 
• Consent to participate 
 
Exclusion criteria: 
• Known learning disability 
• Lack of capacity to give consent 
• Communication difficulties which preclude engagement in an interview 
• Acute psychological distress and/ or the clinical team deems that participation 
would be an additional burden for the individual 
 
- Recruitment procedures 
Clinical teams will be asked to provide a research pack to individuals who would be 
eligible to participate. This will be posted to all eligible families (n = 31). If the 
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adolescent has a clinic appointment scheduled during recruitment period 
(approximately October 2017 – May 2018) then the clinician can discuss the study 
directly with them if there has been no response to the letter.  The research pack will 
include information about the study and an opt-in slip, giving the researcher permission 
to contact them. Alternatively, they can reply by email or call the researcher. An opt-
out slip will also be provided for those who do not wish to be contacted. The researcher 
will then contact interested participants by phone to discuss the study and to obtain 
consent. Those who have not responded to the letter and have not opted out might 
also be contacted by the researcher to check if they are interested.  Also, posters 
advertising the study might be placed in waiting rooms and interested participants can 
contact the researcher directly. There is also a newsletter which is distributed to 
families in Highland and a parents’ group and team website in Glasgow where 
information about the research could be presented. After consent is obtained, a 
suitable time will then be agreed with the participants for the interview. 
 
- Interview 
A semi-structured, in-depth interview will be carried out on a one-to-one basis, lasting 
up to an hour. An interview schedule will enable discussion around the aims of the 
study. Draft interview schedules, which have been reviewed by an expert in the field 
(Dr Louise Phin), are included in appendices 2 and 3.  
 
Creative methods might be employed to facilitate discussion. For example, Veale 
(2005) discusses methods which can be employed to engage children in qualitative 
research, such as a “social mapping” exercise. This involves “mapping” out who helps 
a child and in what way. In a grounded theory study, Christian and D’Auria (1997) used 
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more concrete methods such as enquiring about earliest memories, asking 
adolescents to give advice to a younger child with CF and a timeline of critical events. 
Punch (2002) outlines methods for engaging 13-14 year olds in interviews; such as 
spider diagrams for eliciting information about problems and social support charts. 
  
- Design 
The study will employ a qualitative design using semi-structured interviews. IPA is an 
approach to qualitative data analysis which seeks to understand how people make 
sense of significant experiences through the researcher’s interpretation of the person’s 
narrative account (Smith et al., 2009). Transition into adolescence, particularly with a 
chronic illness which may require increased self-management, could be regarded as 
an important life experience, and as such IPA is favoured over other designs. 
 
- Research procedures 
Using the interview schedule as a guide (see appendices 2 and 3), the researcher will 
initiate discussion to explore topics associated with the aims of the study. Participants 
will be interviewed alone to ensure there is no bias in their answers from having their 
caregiver/adolescent present. A waiting area will be available for anyone waiting for a 
participant. The researcher will remain sensitive to how the interviewee is feeling, and 
adapt the interview accordingly. The interview schedule will be piloted in the first two 
interviews and feedback sought from these participants. Emerging themes will also be 
considered and the interview schedule may be adapted. Interviews will be recorded, 
transcribed, and identifying information removed prior to analysis. 
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- Data analysis 
Data will be analysed using IPA, a method used to understand how people perceive 
significant life experiences (Smith et al., 2009). This involves thorough and repeated 
reading of the data, noting of initial ideas, identifying possible themes and mapping 
out connections between themes. This is repeated for each participant, prior to looking 
for patterns across participants (Smith et al., 2009). An independent researcher will 
analyse a subset of transcripts to ensure the themes which have emerged are similar.  
 
- Justification of sample size 
Smith et al. (2009) advocate between 4 and 10 interviews for professional doctorate 
theses. As both adolescents and caregivers are being recruited then the number of 
interviews is likely to be within the higher range of this estimate.  
 
- Settings and equipment 
Participants will be interviewed within a private room at their respective hospital (Royal 
Hospital for Children/Raigmore). Where possible, this will be on the researcher’s study 
days (Friday, and also Thursday as of April 2018). At the Royal Hospital for Children 
rooms can be booked in the multi-disciplinary team (MDT) hub. Local infection control 
procedures will be followed and the researcher will be trained by a clinician in infection 
control procedures when working with people with CF.  In NHS Highland, rooms are 
bookable at the Phoenix Centre, Raigmore, where paediatric health psychology is 
based. If participants live far from Inverness, rooms are bookable at other satellite 
clinics. Another option is to conduct interviews by phone.  By offering an option to 
those who may not be able to attend a clinic, for example due to difficulties accessing 
transport, childcare etc., a more representative sample can be included. There is 
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evidence to suggest that telephone interviews can yield a similar amount and depth of 
information as face-to-face interviews (Sturges & Hanrahan, 2004). Home visits may 
also be considered for participants who may be unable/unwilling to be interviewed in 
a clinic or by phone. Interviews will be recorded on a digital voice recorder. Access to 
transcribing software and an encrypted laptop will be required for analysis of the data. 
 
Health and safety issues 
- Researcher & participant safety issues 
One-to-one interviews will be conducted in clinic rooms during working hours, and 
usual safe/lone working practices will be followed. A Health and Safety for 
Researchers form is included in appendix 4, detailing the measures which will be taken 
to minimise potential risks to the researcher and participants. Home visits will only be 
conducted in cases where the criteria in section 10 (iii) have been met.    
 
Ethical issues 
Sponsorship will be provided by NHS Highland. An application will be submitted to 
NHS Highland and NHS GG&C Research and Development departments and to the 
Research Ethics Committee. Concurrently, an application will be submitted to NHS 
Research Scotland Permissions Co-ordinating Centre (NRSPCC) for multi-site 
approval. Participants will be asked to provide written consent; if under 16, this will be 
sought from both the adolescent and caregiver/parent (ScotCRN, 2012). If aged 16 or 
above, only the participant will be required to provide consent. Identifiers will be 
removed from the data to allow anonymity and the Data Protection Act 1998 will be 
adhered to. Audio recordings will be held on an encrypted laptop and retained until no 
longer required for the purposes of the project. Prompting individuals to talk about CF 
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could initiate a reflective process about sensitive issues, such as the life-limiting nature 
of their condition. As such, participants may become distressed. The researcher will 
remain aware of the sensitive nature of the discussion and follow the procedure in 
appendix 4, Section 10 (ii) for managing distress.  
 
Financial issues 
Equipment to be borrowed from the University of Glasgow includes a digital voice 
recorder and encrypted laptop. Costs are outlined in appendix 5. As travelling 
expenses are not available from NHS Highland, where possible the researcher will 
plan interviews around travel to Glasgow for teaching.  
 
Timetable 
MRP proposal 30th January 2017 
Final approved MRP proposal and 
paperwork 
15th May 2017 
Apply for ethical approval June-August 2017 
Begin recruitment October 2017 
Analysis February-June 2018 
Write up May - July 2018 
Submission of thesis July 2018 
Viva September 2018 
 
Practical applications 
Understanding the experience of individuals with CF and their families will contribute 
to a greater recognition of how services can best support and meet the needs of 
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families. Understanding how the stress of managing CF impacts on family 
communication and relationships, in both positive and less helpful ways, can help 
teams to understand how best to maintain supportive relationships with adolescents 
and families during the transition period.  This could lead to potential service 
development, such as the provision of new information leaflets; and inform clinical 
practice by allowing clinicians to guide their questioning and tailor intervention.    
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